<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">35816</article-id><article-id pub-id-type="doi">10.7554/eLife.35816</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Differential requirement of kindlin-3 for T cell progenitor homing to the non-vascularized and vascularized thymus</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-107690"><name><surname>Moretti</surname><given-names>Federico Andrea</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3187-3683</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-71456"><name><surname>Klapproth</surname><given-names>Sarah</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-107691"><name><surname>Ruppert</surname><given-names>Raphael</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-107692"><name><surname>Margraf</surname><given-names>Andreas</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-118893"><name><surname>Weber</surname><given-names>Jasmin</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-118894"><name><surname>Pick</surname><given-names>Robert</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-73341"><name><surname>Scheiermann</surname><given-names>Christoph</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-107693"><name><surname>Sperandio</surname><given-names>Markus</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7689-3613</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-20203"><name><surname>Fässler</surname><given-names>Reinhard</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-20628"><name><surname>Moser</surname><given-names>Markus</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8825-5566</contrib-id><email>moser@biochem.mpg.de</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Department Molecular Medicine</institution><institution>Max-Planck-Institute of Biochemistry</institution><addr-line><named-content content-type="city">Martinsried</named-content></addr-line><country>Germany</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Walter Brendel Center of Experimental Medicine, Biomedical Center</institution><institution>Ludwig-Maximilians-Universität</institution><addr-line><named-content content-type="city">Martinsried</named-content></addr-line><country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Gerhardt</surname><given-names>Holger</given-names></name><role>Reviewing Editor</role><aff><institution>Max Delbrück Centre for Molecular Medicine</institution><country>Germany</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Schekman</surname><given-names>Randy</given-names></name><role>Senior Editor</role><aff><institution>Howard Hughes Medical Institute, University of California, Berkeley</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>06</day><month>09</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>7</volume><elocation-id>e35816</elocation-id><history><date date-type="received" iso-8601-date="2018-02-09"><day>09</day><month>02</month><year>2018</year></date><date date-type="accepted" iso-8601-date="2018-08-23"><day>23</day><month>08</month><year>2018</year></date></history><permissions><copyright-statement>© 2018, Moretti et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Moretti et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-35816-v2.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.35816.001</object-id><p>The role of integrin-mediated adhesion during T cell progenitor homing to and differentiation within the thymus is ill-defined, mainly due to functional overlap. To circumvent compensation, we disrupted the hematopoietic integrin regulator kindlin-3 in mice and found a progressive thymus atrophy that is primarily caused by an impaired homing capacity of T cell progenitors to the vascularized thymus. Notably, the low shear flow conditions in the vascular system at midgestation allow kindlin-3-deficient fetal liver-derived T cell progenitors to extravasate via pharyngeal vessels and colonize the avascular thymus primordium. Once in the thymus, kindlin-3 promotes intrathymic T cell proliferation by facilitating the integrin-dependent crosstalk with thymic antigen presenting cells, while intrathymic T cell migration, maturation into single positive CD4 and CD8 T cells and release into the circulation proceed without kindlin-3. Thus, kindlin-3 is dispensable for integrin-mediated T cell progenitor adhesion and signalling at low and indispensable at high shear forces.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>kindlin-3</kwd><kwd>integrin</kwd><kwd>T cell homing</kwd><kwd>thymus development</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>SFB914</award-id><principal-award-recipient><name><surname>Moretti</surname><given-names>Federico Andrea</given-names></name><name><surname>Klapproth</surname><given-names>Sarah</given-names></name><name><surname>Ruppert</surname><given-names>Raphael</given-names></name><name><surname>Margraf</surname><given-names>Andreas</given-names></name><name><surname>Weber</surname><given-names>Jasmin</given-names></name><name><surname>Pick</surname><given-names>Robert</given-names></name><name><surname>Scheiermann</surname><given-names>Christoph</given-names></name><name><surname>Sperandio</surname><given-names>Markus</given-names></name><name><surname>Fässler</surname><given-names>Reinhard</given-names></name><name><surname>Moser</surname><given-names>Markus</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004189</institution-id><institution>Max-Planck-Gesellschaft</institution></institution-wrap></funding-source><award-id>Open-access funding</award-id><principal-award-recipient><name><surname>Moser</surname><given-names>Markus</given-names></name><name><surname>Fässler</surname><given-names>Reinhard</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>T cell progenitor homing into the thymus requires kindlin-3 to stabilize their adhesion to vascular integrin ligands when blood flow velocities and shear rates increase during development.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>T cell progenitors develop in the fetal liver (FL) or in the bone marrow (BM) and require the specialized environment of the thymus to mature into single positive (SP) CD4 or CD8 T cells (<xref ref-type="bibr" rid="bib6">Cai et al., 2007</xref>; <xref ref-type="bibr" rid="bib10">Foss et al., 2001</xref>; <xref ref-type="bibr" rid="bib14">Jotereau et al., 1987</xref>). FL-derived T cell progenitors start colonizing the thymus anlage at around embryonic day (E) 11.5. Since the thymus anlage is initially avascular, T cell progenitors exit the adjacent pharyngeal vessels, migrate towards the thymic primordium, cross the dense extracellular matrix of the thymic capsule and finally settle in the thymic tissue. After thymus vascularization, which occurs at around E15 (<xref ref-type="bibr" rid="bib24">Liu et al., 2006</xref>), T cell progenitors enter the thymus by extravasating from post-capillary venules at the cortico-medullary junction. Once in the thymus the progenitor cells interact and receive signals from thymic epithelial cells, macrophages, dendritic cells (DCs) and extracellular matrix proteins, which are essential for their proliferation, differentiation, selection and release into the circulation as mature, single positive T cells (<xref ref-type="bibr" rid="bib4">Boehm and Bleul, 2006</xref>; <xref ref-type="bibr" rid="bib18">Koch and Radtke, 2011</xref>).</p><p>Leukocyte extravasation follows a cascade of adhesion events commencing with selectin-mediated rolling of leukocytes on endothelial cells followed by the interaction with endothelial cell-bound chemokines, integrin-mediated leukocyte arrest and crawling and finally the transmigration through the vessel wall (<xref ref-type="bibr" rid="bib23">Ley et al., 2007</xref>). Although integrins are expressed on all hematopoietic cells, conflicting reports exist on their role for T cell progenitor extravasation. While the treatment with function-blocking antibodies against α4 and/or β2 integrins reduced the homing of thymic progenitors to the adult thymus (<xref ref-type="bibr" rid="bib39">Rossi et al., 2005</xref>; <xref ref-type="bibr" rid="bib44">Scimone et al., 2006</xref>), genetic ablation of neither α4 (<xref ref-type="bibr" rid="bib1">Arroyo et al., 1996</xref>), nor αL (<xref ref-type="bibr" rid="bib43">Schmits et al., 1996</xref>), α6 (<xref ref-type="bibr" rid="bib11">Georges-Labouesse et al., 1996</xref>), β2 (<xref ref-type="bibr" rid="bib41">Scharffetter-Kochanek et al., 1998</xref>), β7 integrins (<xref ref-type="bibr" rid="bib5">Bungartz et al., 2006</xref>; <xref ref-type="bibr" rid="bib53">Wagner et al., 1996</xref>), or the integrin ligands intercellular adhesion molecule (ICAM)−1 and vascular cell adhesion molecule (VCAM)−1 (<xref ref-type="bibr" rid="bib19">Koni et al., 2001</xref>; <xref ref-type="bibr" rid="bib46">Sligh et al., 1993</xref>; <xref ref-type="bibr" rid="bib56">Xu et al., 1994</xref>) interfered with thymic colonization. Similarly, it is not known whether migration of T cell progenitors within the thymus, or their proliferation and differentiation require integrin-mediated adhesion.</p><p>Kindlins are a family of β integrin tail binding proteins that regulate the affinity of integrins for their ligands and induce signal transduction pathways downstream of activated, ligand-bound integrins (<xref ref-type="bibr" rid="bib34">Moser et al., 2009b</xref>). Kindlins consist of 3 members: kindlin-1,–2, and −3; while kindlin-1 and −2 are widely expressed, hematopoietic cells exclusively express kindlin-3 (<xref ref-type="bibr" rid="bib52">Ussar et al., 2006</xref>; <xref ref-type="bibr" rid="bib54">Weinstein et al., 2003</xref>). Consequently, loss of kindlin-3 impairs the functions of all integrins on hematopoietic cells studied so far and leads to severe defects affecting platelets, leukocytes, osteoclasts and hematopoietic stem and progenitor cells (HSPCs) (<xref ref-type="bibr" rid="bib20">Krüger et al., 2008</xref>; <xref ref-type="bibr" rid="bib33">Moser et al., 2009a</xref>; <xref ref-type="bibr" rid="bib35">Moser et al., 2008</xref>; <xref ref-type="bibr" rid="bib40">Ruppert et al., 2015</xref>; <xref ref-type="bibr" rid="bib42">Schmidt et al., 2011</xref>). In line with genetic studies in mice, loss-of-function mutations in the human <italic>KINDLIN-3/FERMT3</italic> gene cause leukocyte adhesion deficiency type-III (LAD-III) syndrome, which is characterized by severe bleedings, infections and accumulation of HSPCs in the blood circulation (<xref ref-type="bibr" rid="bib21">Kuijpers et al., 2009</xref>; <xref ref-type="bibr" rid="bib27">Malinin et al., 2009</xref>; <xref ref-type="bibr" rid="bib32">Mory et al., 2008</xref>; <xref ref-type="bibr" rid="bib40">Ruppert et al., 2015</xref>; <xref ref-type="bibr" rid="bib48">Svensson et al., 2009</xref>).</p><p>In the present study, we investigated T-lymphopoiesis in kindlin-3-deficient mice. We found that loss of kindlin-3 protein expression results in progressive thymus atrophy, which is mainly caused by impaired colonization of the vascularised thymus by BM-derived T cell progenitors during late embryogenesis and after birth. In contrast, however, colonization of the non-vascularized thymic primordium by kindlin-3-deficient FL-derived progenitors proceeded without kindlin-3, albeit less efficiently, due to the lower vascular shear flow in embryos. Within the thymus anlage, the proliferation rate of kindlin-3-deficient T cell populations was reduced, while differentiation into mature CD4 and CD8 T cells was unaffected. Thus, these findings clearly show the crucial role of integrins during T cell development. Specifically, in the absence of kindlin-3 only a weak integrin-mediated T cell adhesion can occur, which suffices resistance to low systemic shear forces and enables T cell progenitor homing early during development. However, at later time points during development, when vascular shear forces increase, kindlin-3 is critical to stabilize T cell adhesion on endothelial cells allowing T cell progenitor homing into the thymus.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Loss of kindlin-3 protein leads to progressive thymus atrophy</title><p>Kindlin-3 is expressed in CD4/CD8 double negative (DN) and double positive (DP) T cells from wild-type (WT) thymi and SP CD4 and CD8 T cells from WT spleens (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). To test whether kindlin-3 expression is required for thymopoiesis, we investigated thymus morphology and size in kindlin-3-deficient (<italic>Fermt3</italic><sup>-/-</sup>) mice, which die of severe bleedings and anemia within the first week after birth (<xref ref-type="bibr" rid="bib35">Moser et al., 2008</xref>). The morphology of <italic>Fermt3</italic><sup>-/-</sup> thymi was normal and the size steadily increased until postnatal day (P) 3 (<xref ref-type="fig" rid="fig1">Figure 1A,B</xref>). However, while WT thymi continued to grow postnatally, <italic>Fermt3</italic><sup>-/-</sup> thymi shrank and became atrophic (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Consistently, the cellularity of WT thymi continuously increased during development (<xref ref-type="fig" rid="fig1">Figure 1C</xref>), while <italic>Fermt3</italic><sup>-/-</sup> thymi showed an increase in cellularity only until P3, followed by a dramatic decrease at P6 and P8 (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Despite the progressive increase in cellularity until P3 the number of cells was significantly lower in <italic>Fermt3</italic><sup>-/-</sup> thymi compared to controls at all time points analyzed (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Importantly, we did not observe any compensatory expression of kindlin-1 or −2 in kindlin-3-deficient thymi (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>).</p><fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.35816.002</object-id><label>Figure 1.</label><caption><title>Kindlin-3 deficiency causes thymus atrophy.</title><p>(<bold>A and B</bold>) Images from <italic>Fermt3</italic><sup>+/+</sup> (upper panel) and <italic>Fermt3</italic><sup>-/-</sup> (lower panel) thymi isolated at the indicated embryonic and postnatal stages. Scale bars 1 mm. (<bold>C</bold>) Total thymocyte numbers at indicated time points (E14.5 to P8). N(E14.5)=28/28; N(E16.5)=12/12; N(E18.5)=30/21; N(P3)=6/4; N(P8)=3/2. (<bold>D</bold>) Haematoxylin and Eosin staining of paraffin-embedded thymus sections. Scale bar 1 mm. (<bold>E and F</bold>) Frequencies of CD4 and CD8 double negative (DN), double positive (DP) and single positive CD4 and CD8 thymocytes isolated from P3 and P6 thymi. N(P3)=16/18; N(P6)=8/4. Bars indicate means ± standard errors. **p<italic>&lt;</italic>0.01; ***p<italic>&lt;</italic>0.001. See also <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-35816-fig1-v2"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.35816.003</object-id><label>Figure 1—figure supplement 1.</label><caption><title>Kindlin-3 deficiency causes thymus atrophy.</title><p>(<bold>A</bold>) Kindlin-3 expression in protein lysates from FACS sorted CD4/CD8 double negative (DN), CD4/CD8 double positive (DP), CD4 and CD8 single positive thymocytes. GAPDH served as loading control. (<bold>B</bold>) Expression of kindlin-1,–2 and −3 in protein lysates of <italic>Fermt3</italic><sup>+/+</sup> and <italic>Fermt3</italic><sup>-/-</sup> thymi. Keratinocyte and embryonic stem cell (ESC) lysates were used as positive controls for kindlin-1 and −2 expression, respectively. GAPDH was used as loading control. (<bold>C</bold>) Cryosections of P3 <italic>Fermt3</italic><sup>+/+</sup> and <italic>Fermt3</italic><sup>-/-</sup> thymi were stained with anti-pan-laminin (red), anti-CD4 (green) and anti-CD8 (blue) antibodies (left panel), or with anti-pan-cytokeratin (green), anti-PECAM-1 (red) antibodies and DAPI (blue) (right panel). Cells in cyan indicate CD4/CD8 double positive cells. M, medulla; C, cortex; V, vessel; CMJ, cortico-medullary junction. Scale bar 100 µm. Absolute numbers of DN, DP, CD4<sup>+</sup> and CD8<sup>+</sup> thymocytes present in P3 (<bold>D</bold>) and P6 (<bold>E</bold>) thymi. (<bold>F</bold>) Expression of TCRβ, CD3, CD5 and CD24 on DP, CD4<sup>+</sup> and CD8<sup>+</sup> thymocytes from P3 <italic>Fermt3</italic><sup>+/+</sup> and <italic>Fermt3</italic><sup>-/-</sup> thymi analysed by flow cytometry. Isotype matched controls (blue); <italic>Fermt3</italic><sup>+/+</sup> cells (green); <italic>Fermt3</italic><sup>-/-</sup> cells (red). Bars indicate means ± standard errors. **p<italic>&lt;</italic>0.01; ***p<italic>&lt;</italic>0.001.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-35816-fig1-figsupp1-v2"/></fig></fig-group><p>Hematoxylin/eosin (H/E) staining of thymic section at different stages of development revealed a similar formation of medullary islets in P0 WT and <italic>Fermt3</italic><sup>-/-</sup> thymi that enlarged and fused at P3 to produce a large central medulla surrounded by the cortex (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). In line with the normal thymic cyto-architecture at P3, <italic>Fermt3</italic><sup>-/-</sup> thymi displayed normal cortico-medullary junctions (CMJ) that separate CD4/CD8 DP T cells in the cortex from SP CD4 and CD8 T cells in the medulla, and normal epithelial meshes and vascular networks (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>). At P6 and P8, however, the atrophic <italic>Fermt3</italic><sup>-/-</sup> thymi showed a progressive enlargement of the medulla and a strong reduction of the cortex suggesting an imbalanced development towards more mature SP T cells (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). This observation was confirmed by flow cytometry showing that DN T cells containing the most immature intrathymic T cells were significantly reduced at P3 and P6 in <italic>Fermt3</italic><sup>-/-</sup> thymi compared to controls. Notably, while the relative distribution of DP and SP CD4 and CD8 T cells was still comparable between WT and <italic>Fermt3</italic><sup>-/-</sup> thymi at P3, the relative numbers of DP T cells decreased and SP CD4 and CD8 T cells increased in P6 thymi of <italic>Fermt3</italic><sup>-/-</sup> mice (<xref ref-type="fig" rid="fig1">Figure 1E,F</xref>). However, despite the shift towards SP T cell populations in P6 <italic>Fermt3</italic><sup>-/-</sup> thymi, their absolute numbers were still significantly reduced compared to controls (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D,E</xref>). The presence of normal relative SP T cell numbers in <italic>Fermt3</italic><sup>-/-</sup> thymi until P3 suggests that intrathymic T cell differentiation proceeds independently of kindlin-3. This observation was supported by the normal levels of T cell receptor (TCR), CD3 and costimulatory molecules such as CD5 and CD24 on DP and SP T cells (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1F</xref>).</p></sec><sec id="s2-2"><title>Thymocyte proliferation depends on kindlin-3 expression</title><p>To test whether the number of apoptotic thymocytes is altered within the P3 thymus we immunostained thymic sections for cleaved caspase-3 (<xref ref-type="fig" rid="fig2">Figure 2A</xref>) and analysed thymocytes by flow cytometry after annexin V and 7-AAD (7-Aminoactinomycin) staining (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). We found that neither the number (<xref ref-type="fig" rid="fig2">Figure 2C</xref>) nor the frequency (<xref ref-type="fig" rid="fig2">Figure 2D</xref>) of apoptotic cells (annexin V<sup>+</sup>/7-AAD<sup>-</sup>) was altered in <italic>Fermt3</italic><sup>-/-</sup> thymi. Furthermore, the different T cell subsets isolated from WT and <italic>Fermt3</italic><sup>-/-</sup> thymi showed a comparable annexin V staining (<xref ref-type="fig" rid="fig2">Figure 2E</xref>).</p><fig-group><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.35816.004</object-id><label>Figure 2.</label><caption><title>Reduced thymocyte proliferation contributes to thymus atrophy of kindlin-3-deficient mice.</title><p>(<bold>A</bold>) Staining for cleaved caspase-3 counterstained with Mayer´s haematoxylin on paraffin sections of <italic>Fermt3</italic><sup>+/+</sup> and <italic>Fermt3</italic><sup>-/-</sup> P3 thymi. Scale bar 100 µm. (<bold>B</bold>) Single-cell suspensions of thymocytes from control and <italic>Fermt3</italic><sup>-/-</sup> P3 thymi were stained with the apoptotic (Annexin V) and dead cell (7-AAD) markers. Numbers within the FACS blots represent percent of cells within each quadrant. (<bold>C</bold>) Number of apoptotic cells per field of view (fov) observed in (<bold>A</bold>). N = 10. Percentage of early apoptotic cells (Annexin V<sup>+</sup>, 7-AAD<sup>-</sup>) in control and <italic>Fermt3</italic><sup>-/-</sup> thymi (<bold>D</bold>) and in distinct T cell subpopulations (CD4/CD8 DN, CD4/CD8 DP, CD4 single positive and CD8 single positive) (<bold>E</bold>). N = 7/10. (<bold>F</bold>) Sections of <italic>Fermt3</italic><sup>+/+</sup> and <italic>Fermt3</italic><sup>-/-</sup> P3 thymi stained for BrdU incorporation and counterstained with Mayer´s haematoxylin. Scale bar 100 µm. (<bold>G</bold>) BrdU incorporation in thymocytes analysed by flow cytometry. (<bold>H</bold>) Numbers of BrdU positive cells per field of view (fov) observed in (<bold>F</bold>). N = 8/6. (<bold>I</bold>) Percentage of proliferating, BrdU positive thymocytes measured by flow cytometry. N = 14. (<bold>J</bold>) Percentage of BrdU positive cells in distinct T cell subpopulations. N = 14. (<bold>K</bold>) CD4 T cells isolated from spleens of control <italic>Fermt3</italic><sup>fl/fl</sup>/<italic>2D2</italic> and <italic>Fermt3</italic><sup>fl/fl</sup>/<italic>2D2</italic>/<italic>CD4Cre</italic> mice were stained with CFSE and stimulated either with DCs loaded with different concentrations of MOG<sub>35-55</sub> peptide or primed with anti-CD3e/CD28 antibodies and PMA. Representative histograms show CSFE dilution. Red-lined histograms represent cells incubated with not-loaded DCs or no antibodies. Bars indicate means ± standard errors. **p<italic>&lt;</italic>0.01; ***p<italic>&lt;</italic>0.001. See also <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-35816-fig2-v2"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.35816.005</object-id><label>Figure 2—figure supplement 1.</label><caption><title>Reduced thymocyte proliferation contributes to thymus atrophy of kindlin-3-deficient mice.</title><p>Kindlin-3-deficient CD4<sup>+</sup> T cells are able to form immune synapses with dendritic cells. Mature wild-type dendritic cells loaded with MOG35-55 peptide were incubated with CD4<sup>+</sup> T cells from <italic>Fermt3</italic><sup>fl/+</sup> (K3<sup>fl/+</sup>) and <italic>Fermt3</italic><sup>fl/fl</sup> (K3<sup>fl/fl</sup>) mice expressing Cre-recombinase under the control of the CD4 promoter, a MOG35-35 specific TCR (<italic>2D2</italic>) and a double fluorescent reporter transgene to verify Cre activity (<italic>mT/mG</italic>). Cells were stained for intergin LFA-1, tyrosin-phosphorylated proteins and actin and imaged by confocal microscopy. Size bar 10 µm.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-35816-fig2-figsupp1-v2"/></fig></fig-group><p>Next, we determined thymocyte proliferation by in vivo bromodeoxyuridine (BrdU) labelling, which revealed a significantly reduced number of BrdU positive cells in P3 <italic>Fermt3</italic><sup>-/-</sup> thymi both by immunohistochemistry (<xref ref-type="fig" rid="fig2">Figure 2F,H</xref>) and flow cytometry (<xref ref-type="fig" rid="fig2">Figure 2G,I</xref>). Notably, reduced proliferation was detected in both the DP and the SP T cell populations (<xref ref-type="fig" rid="fig2">Figure 2J</xref>). Since thymocyte proliferation relies on proper contact with antigen presenting cells (APC), we tested kindlin-3-deficient T cells for their ability to form immune synapses (IS) with WT DCs. To this end we loaded mature DCs with MOG35-55 peptide and added splenic CD4 T cells from <italic>Fermt3</italic><sup>+/fl</sup> and <italic>Fermt3</italic><sup>fl/fl</sup> mice, which express a TCR transgene specific for the myelin oligodendrocyte glycoprotein (MOG) 35–55 peptide (<italic>2D2</italic>), a double-fluorescent reporter transgene for measuring Cre activity (mTmG) and the CD4-Cre transgene (<xref ref-type="bibr" rid="bib2">Bettelli et al., 2003</xref>; <xref ref-type="bibr" rid="bib31">Moretti et al., 2013</xref>; <xref ref-type="bibr" rid="bib36">Muzumdar et al., 2007</xref>). After 30 min the T-DC contacts were analysed by immunofluorescence staining. Although <italic>Fermt3</italic><sup>-/-</sup> T cells formed fewer contacts with DCs compared to control T cells, recruitment of LFA-1 and actin to the contact area as well as phospho-Tyrosine signals were indistinguishable between them suggesting that <italic>Fermt3</italic><sup>-/-</sup> T cells form IS with DCs (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). To study APC-induced T cell proliferation in vitro, we co-cultured MOG35-55 peptide-loaded dendritic cells with CSFE-labelled control and kindlin-3-deficient T cells derived from <italic>Fermt3</italic><sup>fl/fl</sup>/<italic>CD4-Cre</italic>/<italic>2D2</italic> mice, and measured CSFE dilution by flow cytometry. In line with the observation that <italic>Fermt3</italic><sup>-/-</sup> T cells can form contacts with DCs, a comparable proliferative response was observed when these T cells were stimulated by DCs loaded with high concentration of MOG35-55 peptide or when a strong TCR signal was induced directly with anti-CD3/CD28 antibodies. In contrast, <italic>Fermt3</italic><sup>-/-</sup> T cells failed to proliferate when dendritic cells were loaded with lower concentrations of MOG35-55 peptide (<xref ref-type="fig" rid="fig2">Figure 2K</xref>) indicating that defective integrin-mediated contact between kindlin-3-deficient T cells and APCs causes a reduced proliferative response contributing to thymus atrophy of kindlin-3-deficient mice.</p></sec><sec id="s2-3"><title>T cell progenitor homing to the postnatal thymus</title><p>The reduced CD4 and CD8 DN T cell numbers in <italic>Fermt3</italic><sup>-/-</sup> thymi (<xref ref-type="fig" rid="fig1">Figure 1E,F</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D,E</xref>) point to an impaired T cell progenitor homing to the thymus. Upon homing of T cell progenitors to the thymus, they progress through four DN stages before developing into DP cells. To test whether loss of kindlin-3 affects the early and/or late stages of DN development, we separated lineage-positive thymic cells from lineage-negative (Lin<sup>neg</sup>) DN cells by flow cytometry and gated the latter cell population for high and low CD44 and c-kit expression into DN stage 1 and 2 (DN<sub>1-2</sub>) and DN stage 3 and 4 (DN<sub>3-4</sub>) cells, respectively. In parallel, we gated DN cells for high and low CD44 and CD25 expression to discriminate between the four DN stages. These experiments revealed that the Lin<sup>neg</sup> DN population was significantly reduced in P3 and P6 thymi and the DN1 and DN2 stage thymocytes were virtually absent from P3 <italic>Fermt3</italic><sup>-/-</sup> thymi (<xref ref-type="fig" rid="fig3">Figure 3A</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). DN1 stage cells are the immediate intrathymic descendants of circulating hematopoietic progenitor cells (Lin<sup>neg</sup>, c-kit<sup>+</sup>, Sca-1<sup>-</sup> and Sca-1<sup>+</sup>), which accumulate in the blood circulation of <italic>Fermt3</italic><sup>-/-</sup> mice suggesting that extravasation of <italic>Fermt3</italic><sup>-/-</sup> T cell progenitors is impaired (<xref ref-type="fig" rid="fig3">Figure 3B,C</xref>). To test this hypothesis experimentally, we transferred FL cells from E14.5 WT and <italic>Fermt3</italic><sup>-/-</sup> embryos into RAG2-deficient (<italic>Rag2</italic><sup>-/-</sup>) mice, in which T cell development is blocked at the DN3 stage due to loss of V(D)J rearrangement (<xref ref-type="bibr" rid="bib45">Shinkai et al., 1992</xref>) and analysed size, weight and cellularity of the chimeric thymus and T cell frequency in the peripheral blood 8 to 10 weeks later. The transfer of <italic>Fermt3</italic><sup>-/-</sup> FL cells failed to reconstitute T cell development in the thymus of <italic>Rag2</italic><sup>-/-</sup> recipient mice (<xref ref-type="fig" rid="fig4">Figure 4A–C</xref>), which also contained almost no DN<sub>1-2</sub> cells (<xref ref-type="fig" rid="fig4">Figure 4D,E</xref>). Interestingly, a very small number of <italic>Fermt3</italic><sup>-/-</sup> T cell progenitors entered the <italic>Rag2</italic><sup>-/-</sup> recipient thymus, differentiated into DN4 cells (<xref ref-type="fig" rid="fig4">Figure 4D,F</xref>) and produced a small number of circulating CD4 and CD8 T cells, which homed to the spleen of <italic>Rag2</italic><sup>-/-</sup> mice (<xref ref-type="fig" rid="fig4">Figure 4G–K</xref>) indicating that kindlin-3 is very important for T cell progenitor homing to the adult thymus, but once in the thymus the progenitor cells differentiate into mature SP T cells that are released into the circulation.</p><fig-group><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.35816.006</object-id><label>Figure 3.</label><caption><title>Reduced frequencies of T cell progenitors in <italic>Fermt3</italic><sup>-/-</sup> thymi.</title><p>(<bold>A</bold>) Thymocytes from <italic>Fermt3</italic><sup>+/+</sup> and <italic>Fermt3</italic><sup>-/-</sup> mice were stained for lineage markers (B220, CD19, TER119, NK1.1, CD11b, Gr-1, CD8α, CD3e, TCRβ, TCRγδ and CD11c), CD44 and c-kit to identify DN<sub>1-2</sub> (Lin<sup>neg</sup>, c-kit<sup>hi</sup>, CD44<sup>hi</sup>) and the DN<sub>3-4</sub> (Lin<sup>neg</sup>, c-kit<sup>low</sup>, CD44<sup>low</sup>) populations. (<bold>B and C</bold>) PB from <italic>Fermt3</italic><sup>+/+</sup> and <italic>Fermt3</italic><sup>-/-</sup> animals (<bold>P3</bold>) were stained for lineage markers (TER119, B220, CD11b, Gr-1, CD11c, NK1.1, CD4 and CD8α), c-kit and Sca-1 to identify hematopoietic progenitor cells and analysed by flow cytometry. N = 4. Numbers within the representative FACS plots indicate cell percentages. Bars indicate means ± standard errors. **p<italic>&lt;</italic>0.01; ***p<italic>&lt;</italic>0.001. See also <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-35816-fig3-v2"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.35816.007</object-id><label>Figure 3—figure supplement 1.</label><caption><title>Reduced frequencies of T cell prognitors in <italic>Fermt3<sup>-/-</sup></italic> thymi.</title><p>Thymocytes from <italic>Fermt3</italic><sup>+/+</sup> and <italic>Fermt3</italic><sup>-/-</sup> P3 mice were stained for lineage markers (B220, CD19, TER119, NK1.1, CD11b, Gr-1, CD8α, CD3ε, TCRβ, TCRγδ and CD11c), CD44 and CD25 to identify and quantify DN1 (Lin<sup>neg</sup>, CD44<sup>hi</sup>, CD25<sup>-</sup>), DN2 (Lin<sup>neg</sup>, CD44<sup>hi</sup>, CD25<sup>+</sup>), DN3 (Lin<sup>neg</sup>, CD44<sup>low</sup>, CD25<sup>+</sup>) and DN4 (Lin<sup>neg</sup>, CD44<sup>low</sup>, CD25<sup>-</sup>) populations by flow cytometry. Numbers within FACS plots indicate cell percentages. Total number of DN1, DN2, DN3 and DN4 cells were measured by flow cytometry. N = 20. Bars indicate means ± standard errors. *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-35816-fig3-figsupp1-v2"/></fig></fig-group><fig-group><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.35816.008</object-id><label>Figure 4.</label><caption><title>Kindlin-3-deficient T cell progenitors are severely impaired in seeding the adult thymus.</title><p>(<bold>A–C</bold>) Images (<bold>A</bold>), weights (<bold>B</bold>) and cell numbers (<bold>C</bold>) of thymi from adult WT and <italic>Rag2</italic><sup>-/-</sup> mice and <italic>Rag2</italic><sup>-/-</sup> mice 10 weeks after reconstitution with <italic>Fermt3</italic><sup>+/+</sup> and <italic>Fermt3</italic><sup>-/-</sup> fetal liver cells. Scale bar 5 mm. N = 10. (<bold>D</bold>) Single-cell suspensions were stained for lineage markers (B220, CD19, TER119, NK1.1, CD11b, Gr-1, CD11c, CD8α, CD3e, TCRβ, and TCRγδ), c-kit, CD44 and CD25 to identify the DN<sub>1-2</sub> (Lin<sup>neg</sup>, c-kit<sup>hi</sup>, CD44<sup>hi</sup>) and the DN<sub>3-4</sub> (Lin<sup>neg</sup>, c-kit<sup>low</sup>, CD44<sup>low</sup>) populations (upper panel), and DN1 (Lin<sup>neg</sup>, CD44<sup>hi</sup>, CD25<sup>-</sup>), DN2 (Lin<sup>neg</sup>, CD44<sup>hi</sup>, CD25<sup>+</sup>), DN3 (Lin<sup>neg</sup>, CD44<sup>low</sup>, CD25<sup>+</sup>) and DN4 (Lin<sup>neg</sup>, CD44<sup>low</sup>, CD25<sup>-</sup>) populations (lower panel) by flow cytometry. Frequencies of DN<sub>1-2</sub> (<bold>E</bold>) and DN4 (<bold>F</bold>) thymocytes. N = 8–10. (<bold>G</bold>) Analysis of peripheral blood T-lymphocytes. (<bold>H and I</bold>) Frequencies of circulating CD4<sup>+</sup> and CD8<sup>+</sup> T cells calculated from flow cytometric analyses shown in (<bold>G</bold>). N = 10. Numbers within the representative FACS plots indicate cell percentages. (<bold>J</bold>) Expression of talin-1 and kindlin-3 in CD4<sup>+ </sup>T cells isolated from the spleen of <italic>Rag2</italic><sup>-/-</sup> mice after reconstitution with <italic>Fermt3</italic><sup>+/+</sup> and <italic>Fermt3</italic><sup>-/-</sup> fetal liver cells. GAPDH serves as loading control. (<bold>K</bold>) genomic PCR of CD8<sup>+</sup> T cells sorted from the spleen of <italic>Rag2</italic><sup>-/-</sup>/<italic>Fermt3</italic><sup>+/+</sup> and <italic>Rag2</italic><sup>-/-</sup>/<italic>Fermt3</italic><sup>-/-</sup> chimeras. Numbers within the representative FACS plots indicate cell percentages. Bars indicate means ± standard errors. **p<italic>&lt;</italic>0.01; ***p<italic>&lt;</italic>0.001. See also <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplements 1</xref> and <xref ref-type="fig" rid="fig4s2">2</xref>.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-35816-fig4-v2"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.35816.009</object-id><label>Figure 4—figure supplement 1.</label><caption><title>Kindlin-3-deficient T cell progenitors are severely impaired in seeding the adult thymus.</title><p>(<bold>A</bold>) Thymocytes from polyIC-induced <italic>Fermt3</italic><sup>fl/fl</sup>/<italic>Mx1-Cre</italic>-negative and <italic>Fermt3</italic><sup>fl/fl</sup>/<italic>Mx1-Cre</italic>-positive mice were stained for lineage markers (B220, CD19, TER119, NK1.1, CD11b, Gr-1, CD8α, CD3ε, TCRβ, TCRγδ and CD11c), CD44 and c-kit to identify the DN<sub>1-2</sub> population (Lin<sup>neg</sup>, c-kit<sup>hi</sup>, CD44<sup>hi</sup>). (<bold>B</bold>) Cell numbers, weight and flow cytometric analyses of thymi from mixed FL cell chimeras, which received a 9:1 ratio of FL cells from <italic>Fermt3</italic><sup>+/+</sup> or <italic>Fermt3</italic><sup>-/-</sup> embryos (CD45.2) and WT B6.SJL FL cells (CD45.1). Cells were stained for CD45.2, CD4 and CD8. Numbers within FACS plots indicate cell percentages. Frequencies of DP, DN and SP CD4 and CD8 T cells were calculated from flow cytometric analyses. N = 8/10. Bars indicate means ± standard errors.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-35816-fig4-figsupp1-v2"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.35816.010</object-id><label>Figure 4—figure supplement 2.</label><caption><title>Kindlin-3-deficient T cell progenitors are severely impaired in seeding the adult thymus.</title><p>Kindlin-3 is exclusively expressed in hematopoietic cells of the thymus. (<bold>A</bold>) Single cell suspensions of thymi from E15.5 embryos of WT (+/+) and Kindlin-3-EGFP knockin (<italic>Fermt3</italic>-EGFP ki/ki) mice were stained for CD45.2 and the thymic epithelial marker EpCAM. Both populations were analysed for EGFP expression. (<bold>B</bold>) Thymic cells from adult WT and <italic>Fermt3</italic>-EGFP knockin mice were stained for CD45.2, CD3, CD31 and EpCAM to distinguish between hematopoietic, endothelial and thymic epithelial cells. All subpopulations were analysed for EGFP expression.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-35816-fig4-figsupp2-v2"/></fig></fig-group><p>Since kindlin-3-deficient HSCs show an approximately 5-fold reduced homing capacity to the bone marrow, which might eventually impact on T cell progenitor generation (<xref ref-type="bibr" rid="bib40">Ruppert et al., 2015</xref>), we conditionally deleted <italic>Fermt3</italic> by injecting polyIC into <italic>Fermt3</italic><sup>fl/fl</sup>/<italic>Mx1-Cre</italic> mice and detected almost no DN (Lin<sup>neg</sup>) cells in their thymi, whereas control thymi from polyIC-treated <italic>Fermt3</italic><sup>fl/fl</sup> mice clearly contained a discrete population of DN<sub>1-2</sub> stage T cells (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). In addition, we generated mixed FL cell chimeras by transferring nine times more <italic>Fermt3</italic><sup>-/-</sup> FL cells than WT FL cells into lethally irradiated recipient mice and compared their homing capacity to the thymus. To discriminate between both cell populations the WT FL cells were isolated from B6.SJL embryos, which express the CD45.1 allelic variant, while the <italic>Fermt3</italic><sup>-/-</sup> embryos are from a C57BL/6 background expressing CD45.2. Despite the excess in transferred kindlin-3-deficient FL cells, only around 25% of the DN cells were of CD45.2 origin. As a control, chimeras made from 90% WT CD45.2 cells and 10% WT B6.SJL CD45.1 cells showed the 9:1 ratio in DN and all later T cell stages (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>). Moreover, to exclude a defect in a non-hematopoietic cell type as cause for the <italic>Fermt3</italic><sup>-/-</sup> T cell progenitor homing defect, we analysed thymi from Kindlin-3-EGFP knockin mice, which express kindlin-3 tagged C-terminally with EGFP. Flow cytometry of their thymi revealed that only CD45<sup>+</sup> leukocytes were EGFP-positive and that CD31<sup>+</sup> endothelial cells and EPCAM<sup>+</sup> thymic epithelial cells were EGFP negative (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>). Altogether, these experiments show that kindlin-3-deficient T cell progenitors have a strong defect in homing to the postnatal and adult thymus and that the homing defect is of hematopoietic origin.</p></sec><sec id="s2-4"><title>T cell progenitor homing to the thymus primordium</title><p>Since thymi of newborn <italic>Fermt3</italic><sup>-/-</sup> mice lacked DN1 and DN2 cells but contained DN3 and DN4 cells (<xref ref-type="fig" rid="fig3">Figure 3A</xref>) we surmised that during development significant numbers of T cell progenitors from the FL must be able to colonize the fetal thymus. To test this hypothesis, we determined numbers and locations of CD45<sup>+</sup> hematopoietic progenitor cells in sections of the thymus primordium at different time points. In line with previous reports (<xref ref-type="bibr" rid="bib8">Douagi et al., 2000</xref>; <xref ref-type="bibr" rid="bib13">Itoi et al., 2001</xref>), we observed the first wave of WT CD45<sup>+</sup> progenitor cells within the perithymic mesenchyme at E11.5, and initial migration into the thymus primordium at E12.0 and scattering throughout the thymus at E12.5 and E13.5 (<xref ref-type="fig" rid="fig5">Figure 5A–F</xref>). Interestingly, also <italic>Fermt3</italic><sup>-/-</sup> progenitor cells could be detected in the thymus primordium and the surrounding mesenchyme, however at lower numbers (<xref ref-type="fig" rid="fig5">Figure 5A–E</xref>). Despite the reduction, CD45<sup>+</sup> progenitor cells accumulated at E13.5 in the <italic>Fermt3</italic><sup>-/-</sup> thymus (<xref ref-type="fig" rid="fig5">Figure 5D</xref>) and continued developing into DN<sub>1-2</sub> cells (<xref ref-type="fig" rid="fig5">Figure 5F</xref>). Strikingly, a dramatic drop in the DN<sub>1-2</sub> population was observed in <italic>Fermt3</italic><sup>-/-</sup> thymi at E15-16 (<xref ref-type="fig" rid="fig5">Figure 5G,H</xref> and <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A,B</xref>).</p><fig-group><fig id="fig5" position="float"><object-id pub-id-type="doi">10.7554/eLife.35816.011</object-id><label>Figure 5.</label><caption><title>Kindlin-3-independent colonization of the fetal thymus.</title><p>(<bold>A–D</bold>) Sagittal sections of whole embryos at gestational ages E11.5 (<bold>A</bold>), E12 (<bold>B</bold>), E12.5 (<bold>C</bold>) and E13.5 (<bold>D</bold>) were stained for fibronectin (perithymic mesenchyme, blue), cytokeratin (thymic primordium, green) and CD45 (potential T cell progenitor cells, red). Scale bars 100 µm. (<bold>E</bold>) Numbers of CD45<sup>+</sup> cells within the thymic primordium and in the perithymic mesenchyme at the indicated time points. N = 3–4. (<bold>F</bold>) Representative flow cytometric profiles of fetal thymocytes from control and <italic>Fermt3</italic><sup>-/-</sup> thymi at the indicated time points stained for lineage markers (B220, CD19, TER119, NK1.1, CD11b, Gr-1, CD11c, CD8α, CD3e, TCRβ, and TCRγδ), c-kit and CD44 to identify the DN<sub>1-2</sub> (Lin<sup>neg</sup>, c-kit<sup>hi</sup>, CD44<sup>hi</sup>) and the DN<sub>3-4</sub> (Lin<sup>neg</sup>, c-kit<sup>low</sup>, CD44<sup>low</sup>) populations. Numbers within the representative FACS plots indicate cell percentages. Frequencies (<bold>G</bold>) and total number (<bold>H</bold>) of DN<sub>1-2</sub> cells measured in the flow cytometric analyses shown in (<bold>F</bold>). N = 7–10 Bars indicate means ± standard errors. *p<italic>&lt;</italic>0.05; **p<italic>&lt;</italic>0.01; ***p<italic>&lt;</italic>0.001. See also <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-35816-fig5-v2"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.35816.012</object-id><label>Figure 5—figure supplement 1.</label><caption><title>Kindlin-3-independent colonization of the fetal thymus.</title><p>Kindlin-3-deficient T cell progenitors colonize the fetal thymus but decrease with age. Thymocytes from <italic>Fermt3</italic><sup>+/+</sup> and <italic>Fermt3</italic><sup>-/-</sup> E15.5 (<bold>A</bold>) and E18.5 (<bold>B</bold>) embryos were stained for lineage markers (B220, CD19, TER119, NK1.1, CD11b, Gr-1, CD8α, CD3ε, TCRβ, TCRγδ and CD11c), CD44 and CD25 to identify and quantify DN1 (Lin<sup>neg</sup>, CD44<sup>hi</sup>, CD25<sup>-</sup>), DN2 (Lin<sup>neg</sup>, CD44<sup>hi</sup>, CD25<sup>+</sup>), DN3 (Lin<sup>neg</sup>, CD44<sup>low</sup>, CD25<sup>+</sup>) and DN4 (Lin<sup>neg</sup>, CD44<sup>low</sup>, CD25<sup>-</sup>) populations by flow cytometry. Numbers within FACS plots indicate cell percentages. Total number of DN1, DN2, DN3 and DN4 cells were measured by flow cytometry. N = 6–8. Bars indicate means ± standard errors. *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-35816-fig5-figsupp1-v2"/></fig></fig-group><p>Next we tested whether an abnormal <italic>Fermt3</italic><sup>-/-</sup> progenitor cell development in the FL or release from the FL into the circulation caused the reduced colonization of the thymus primordium. The flow cytometric analyses revealed that the absolute numbers of Lin<sup>neg</sup>, c-kit<sup>hi</sup>, CD45<sup>+</sup>, PIR<sup>+</sup> T cell progenitors were comparable between WT and <italic>Fermt3</italic><sup>-/-</sup> FLs, while their frequency, due to a decreased cellularity of <italic>Fermt3</italic><sup>-/-</sup> FLs, was increased (<xref ref-type="fig" rid="fig6">Figure 6A–C</xref>). The numbers of circulating WT and <italic>Fermt3</italic><sup>-/-</sup> Lin<sup>neg</sup>, c-kit<sup>hi</sup>, PIR<sup>+</sup> T cell progenitors increased between E11.5 to E12. However, while the frequency of WT T cell progenitors steadily decreased between E12 and E13.5, the T cell progenitors accumulated in the circulation of <italic>Fermt3</italic><sup>-/-</sup> fetuses due to their reduced extravasation from pharyngeal vessels and/or impaired migration towards the thymus primordium (<xref ref-type="fig" rid="fig6">Figure 6D,E</xref>).</p><fig id="fig6" position="float"><object-id pub-id-type="doi">10.7554/eLife.35816.013</object-id><label>Figure 6.</label><caption><title>Fetal liver-derived T cell progenitors accumulate in the blood.</title><p>(<bold>A</bold>) Fetal liver cells from control and <italic>Fermt3</italic><sup>-/-</sup> embryos from indicated gestational stages were stained for lineage markers (B220, CD19, TER119, NK1.1, Gr-1 and Thy1.2), c-kit, CD45 and PIR and analysed by flow cytometry. Frequencies (<bold>B</bold>) and total numbers (<bold>C</bold>) of PIR<sup>+</sup> T cell progenitors per fetal liver. N(E12.5)=7/6; N(E13.5)=8/5; N(E14.5)=10/11; N(E15.5)=4/7. (<bold>D</bold>) FB from <italic>Fermt3</italic><sup>+/+</sup> and <italic>Fermt3</italic><sup>-/-</sup> embryos were stained for lineage markers (B220, CD19, TER119, NK1.1, Gr-1 and Thy1.2), c-kit and PIR and analysed by flow cytometry. (<bold>E</bold>) Frequencies of circulating PIR<sup>+</sup> T cell progenitors determined in (<bold>D</bold>). N(E11.5)=5; N(E12)=8/3; N(E12.5)=4/5; N(E13.5)=7/6. Numbers within the representative FACS plots indicate cell percentages. Bars indicate means ± standard errors. *p<italic>&lt;</italic>0.05; **p<italic>&lt;</italic>0.01; ***p<italic>&lt;</italic>0.001.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-35816-fig6-v2"/></fig><p>T cell progenitor homing to the thymus is directed by chemokine gradients produced by thymic epithelial cells (<xref ref-type="bibr" rid="bib18">Koch and Radtke, 2011</xref>). Therefore, we decided to test whether <italic>Fermt3</italic><sup>-/-</sup> progenitors are able to sense the chemokine gradient released by thymic lobes in vitro and to invade the thymus. To this end, thymic lobes from WT E15.5 SJL embryos (CD45.1<sup>+</sup>) were depleted from their T cells with deoxyguanosine (dGuo) and then positioned in a collagen matrix in close proximity to FL-derived Lin<sup>neg</sup> cells from WT or <italic>Fermt3</italic><sup>-/-</sup> E14.5 C57BL/6 (CD45.2<sup>+</sup>) embryos (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). Progenitor migration towards the thymic lobes was monitored for 36 to 48 hr by time-lapse video microscopy, which revealed that WT as well as <italic>Fermt3</italic><sup>-/-</sup> FL cells moved persistently towards the thymic lobes, while migration was not induced when thymic lobes were absent (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). To further test whether FL-derived T cell progenitor cells had invaded the thymus capsule and developed into mature T cells ex vivo, the lobes were recovered from the collagen matrix and cultured for additional 18 days under conventional fetal thymus organ culture (FTOC) conditions (<xref ref-type="fig" rid="fig7">Figure 7C</xref>). Consistent with our in vivo data, CD45.2<sup>+</sup> <italic>Fermt3</italic><sup>-/-</sup> donor cells normally developed into DP, CD4 and CD8 SP cells (<xref ref-type="fig" rid="fig7">Figure 7D</xref>).</p><fig id="fig7" position="float"><object-id pub-id-type="doi">10.7554/eLife.35816.014</object-id><label>Figure 7.</label><caption><title>Kindlin-3-deficient T cell progenitors home to the fetal thymus and further develop into SP T cells ex vivo.</title><p>(<bold>A</bold>) Schematic description of the thymus attraction experiment. (<bold>B</bold>) Representative images of the thymus attraction experiment at the beginning and 40 hr after starting the experiment. Lin<sup>neg</sup> fetal liver cells from control or <italic>Fermt3</italic><sup>-/-</sup> embryos (both CD45.2<sup>+</sup>) are seen in the upper right corner of the images, a dGuo-treated wild-type fetal thymus lobe (FT, CD45.1<sup>+</sup>) is located at the lower left corner. Scale bar 250 µm. (<bold>C</bold>) Schematic description of the fetal thymus organ culture. (<bold>D</bold>) dGuo-treated fetal thymus lobes seeded with fetal liver cells as performed in (<bold>B</bold>) were further cultured for 18 days. Cells were stained for CD45.1, CD45.2, CD4, and CD8. Numbers within the representative FACS plots indicate cell percentages.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-35816-fig7-v2"/></fig><p>Altogether these findings indicate that <italic>Fermt3</italic><sup>-/-</sup> T cell progenitors normally develop in the FL, are released into the circulation, sense the chemokine gradient, leave the pharyngeal vessel, albeit less efficiently than WT T cell progenitors, migrate towards the thymus primordium, invade the thymus capsule and differentiate into different T cell subsets.</p></sec><sec id="s2-5"><title>Blood flow velocity modulates <italic>Fermt3</italic><sup>-/-</sup> T cell progenitor adhesion to vascular walls</title><p>The differential efficacy of <italic>Fermt3</italic><sup>-/-</sup> T cell progenitor homing to the avascular and vascularized thymus was neither due to different kindlin-3 and talin-1 protein levels in lysates from sorted FL-derived T progenitor cells (Lin<sup>neg</sup>, c-kit<sup>+</sup>, PIR<sup>+</sup>) isolated from E13.5 embryos and DN1 cells (Lin<sup>neg</sup>, CD44<sup>+</sup>, CD25<sup>-</sup>) isolated from P6 thymi nor from an upregulation of talin-1 in <italic>Fermt3</italic><sup>-/-</sup> PIR<sup>+</sup> T cell progenitors (<xref ref-type="fig" rid="fig8">Figure 8A,B</xref>). Flow cytometry also excluded differences in surface expression of α4, αL, β1, β2, β3 and β7 integrins on FL-derived T progenitor cells (Lin<sup>neg</sup>, c-kit<sup>+</sup>, PIR<sup>+</sup>) (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1</xref>) and BM-derived LSK cells (<xref ref-type="bibr" rid="bib40">Ruppert et al., 2015</xref>). Similarly, the CD31-positive vascular network was indistinguishable in E13.5 and E15.5 thymi from WT and <italic>Fermt3</italic><sup>-/-</sup> mice excluding the possibility that a potential kindlin-3 expression in endothelial cells (<xref ref-type="bibr" rid="bib3">Bialkowska et al., 2010</xref>) accounts for the defective homing to the vascularized thymus (data not shown). Since adhesion and extravasation of <italic>Fermt3</italic><sup>-/-</sup> T cells can occur on inflamed endothelium expressing high levels of VCAM-1 and ICAM-1 (<xref ref-type="bibr" rid="bib28">Manevich-Mendelson et al., 2009</xref>; <xref ref-type="bibr" rid="bib31">Moretti et al., 2013</xref>), we determined the expression of VCAM-1, ICAM-1 and ICAM-2 by immunostaining and flow cytometry and found them even lower expressed in pharyngeal vessels compared to intrathymic vessels. Thus this also excludes that an elevated adhesion molecule expression on pharyngeal vessels compared to intrathymic vessels accounts for the better adhesion and extravasation (<xref ref-type="fig" rid="fig8s2">Figure 8—figure supplement 2A–E</xref>).</p><fig-group><fig id="fig8" position="float"><object-id pub-id-type="doi">10.7554/eLife.35816.015</object-id><label>Figure 8.</label><caption><title>Kindlin-3 is important to stabilize the adhesion of T cell progenitors and mature T cells to vascular integrin ligands when blood flow velocities and shear rate levels increase during development and in vessel segments of higher blood flow within lymph nodes.</title><p>(<bold>A</bold>) Talin and kindlin-3 expression in FACS-sorted Pir<sup>+</sup> T cell progenitor cells from WT FL of E13.5 embryos compared to DN1 cells sorted from the thymus of P6 mice. GAPDH served as loading control. (<bold>B</bold>) Talin and kindlin-3 expression in control and kindlin-3<sup>-/-</sup> Pir<sup>+</sup> T cell progenitor cells isolated from E13.5 FL. GAPDH served as loading control. Mean blood flow velocities (<bold>C</bold>) and shear rates (<bold>D</bold>) within the yolk sac vasculature of E12.5 to E16.5 embryos were determined by intravital microscopy. N = 14/3/8/21/18. (<bold>E and F</bold>) Relative adhesion of Pir<sup>+</sup> T cell progenitor cells FACS-sorted from the FLs of control and <italic>Fermt3</italic><sup>-/-</sup> E13.5 embryos on ICAM-1, P-selectin, CCL21 and CCL25 or on VCAM-1, P-selectin, CCL21 and CCL25 coated ibidi flow chambers with stepwise increasing shear rates. N ≥ 5. Bars indicate means ± standard deviation. (<bold>G</bold>) Purity of CD4<sup>+</sup> T cells from WT and <italic>Fermt3</italic> hypomorphic (n/-) mice that have been labelled with CFSE and Far Red and mixed in a 1:1 ratio. Grey line represents isotype control. (<bold>H,I</bold>) Adhesion of CD4<sup>+</sup> T cells in vivo. (<bold>H</bold>) Representative microscopic images of adherent (+/+, red) and (n/-, green) cells in the lymph node vasculature after adoptive transfer. Sum intensity Z projections of confocal stacks are shown. Segmented lines indicate vessel outlines. Scale bar = 50 µm. (<bold>I</bold>) Quantification of adherent CD4<sup>+</sup> T cells (N = 18–19 vessels from three mice). (<bold>J, K</bold>) Microvascular blood flow in the lymph node vasculature. (<bold>J</bold>) Centerline blood flow velocity and (<bold>K</bold>) vascular shear rate in LN microvessel segments (N = 25–27 field of views from three mice). Bars indicate means ± standard deviation. **p<italic>&lt;</italic>0.01; ***p<italic>&lt;</italic>0.001. See also <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplements 1</xref> and <xref ref-type="fig" rid="fig8s2">2</xref>.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-35816-fig8-v2"/></fig><fig id="fig8s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.35816.016</object-id><label>Figure 8—figure supplement 1.</label><caption><title>Kindlin-3 is important to stabilize the adhesion of T cell progenitors and mature T cells to vascular integrin ligands when blood flow velocities and shear rate levels increase during development and in vessel segments of higher blood flow within lymph nodes.</title><p>Surface expression of integrins on HPCs (Lin<sup>neg</sup>, c-kit<sup>+</sup>) and T cell progenitors (Lin<sup>neg</sup>, c-kit<sup>+</sup>, PIR<sup>+</sup>). FL cells from E13.5 control and <italic>Fermt3</italic><sup>-/-</sup> embryos were stained for lineage markers (B220, CD19, TER119, NK1.1, Gr-1 and Thy1.2), c-kit, PIR and one of the indicated integrins.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-35816-fig8-figsupp1-v2"/></fig><fig id="fig8s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.35816.017</object-id><label>Figure 8—figure supplement 2.</label><caption><title>Kindlin-3 is important to stabilize the adhesion of T cell progenitors and mature T cells to vascular integrin ligands when blood flow velocities and shear rate levels increase during development and in vessel segments of higher blood flow within lymph nodes.</title><p>ICAM-1 (<bold>A</bold>) and VCAM-1 (<bold>B</bold>) expression was quantified by measuring the fluorescence intensities of immunofluorescence stainings of CD31<sup>+</sup> pharyngeal vessels at E12.5 and E13.5 and intrathymic vessels at E18.5. N = 3. (<bold>C–E</bold>) Flow cytometric analysis of ICAM-1 (<bold>C</bold>), ICAM-2 (<bold>D</bold>) and VCAM-1 (<bold>E</bold>) expression of CD31<sup>+</sup> endothelial cells from the thymus/neck region of E12.5, E13.5 and E18.5 embryos. N = 3. Bars indicate means ± standard deviation. Bars indicate means ±standard deviation.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-35816-fig8-figsupp2-v2"/></fig></fig-group><p>Integrin-mediated adhesion of T cells to endothelial adhesion molecules is influenced by the existing vascular shear stress (<xref ref-type="bibr" rid="bib31">Moretti et al., 2013</xref>). We therefore hypothesized that <italic>Fermt3</italic><sup>-/-</sup> T cell progenitors show impaired adhesion to the vascular endothelium when blood flow velocity and shear forces increase during intrauterine development. To test this hypothesis, we injected red fluorescent microbeads into the yolk-sac vasculature of E12.5 to E16.5 embryos and measured blood flow velocity by intravital microscopy. We found an increase in blood flow velocity (<xref ref-type="fig" rid="fig8">Figure 8C</xref>) and shear rates (<xref ref-type="fig" rid="fig8">Figure 8D</xref>) between E12.5 to 16.5. Accordingly, in vitro flow chamber assays revealed that isolated T cell progenitors (Lin<sup>neg</sup>, c-kit<sup>+</sup>, CD45<sup>+</sup>, Pir<sup>+</sup>) hardly adhered to P-selectin, CCL21/CCL25 and ICAM-1 (<xref ref-type="fig" rid="fig8">Figure 8E</xref>), while they readily adhered to P-selectin, CCL21/CCL25 and VCAM-1 in a shear stress-dependent manner. Interestingly, <italic>Fermt3</italic><sup>-/-</sup> T cell progenitors adhered to VCAM-1 but displayed a significantly reduced shear force resistance (<xref ref-type="fig" rid="fig8">Figure 8F</xref>) suggesting that the increase in blood flow velocity and shear forces during fetal development prevents <italic>Fermt3</italic><sup>-/-</sup> T cell progenitor adhesion and extravasation at intrathymic vessels. To demonstrate that a strong reduction in kindlin-3 expression only allows adhesion of T cells to the vascular surface at sites with lower shear rates, we adoptively transferred a 1:1 ratio of CSFE and Far Red-labelled CD4 T cells from spleens and LNs of WT and <italic>Fermt3</italic> hypomorphic mice (K3n/-), respectively, into recipient mice and analysed their adhesion to the popliteal LN vasculature by spinning disc confocal microscopy (<xref ref-type="fig" rid="fig8">Figure 8G,H</xref>). <italic>Fermt3</italic> hypomorphic mice express only 5% kindlin-3 protein and therefore show a strong defect in leukocyte adhesion (<xref ref-type="bibr" rid="bib17">Klapproth et al., 2015</xref>). As expected, we observed a reduced number of adherent <italic>Fermt3</italic> hypomorphic T cells in the LN vasculature compared to WT cells (<xref ref-type="fig" rid="fig8">Figure 8H,I</xref>). We then injected fluorescent microspheres and measured the blood flow velocities in LN vessel segments and determined shear rates adherent cells were exposed to in those vessels. We found that <italic>Fermt3</italic> hypomorphic cells adhered preferentially in vessel segments where blood flow velocity and shear rates were lower compared to WT T cells. The latter adhered to vessel segments with higher blood flow velocities and shear rates (<xref ref-type="fig" rid="fig8">Figure 8J,K</xref>). These findings indicate that kindlin-3 is crucial to stabilize integrin-mediated T cell adhesion to vessel walls exposed to high vascular shear forces.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In the present study, we used mice lacking the essential integrin regulatory protein kindlin-3 to address the role of integrin-mediated adhesion and signalling during T cell progenitor homing to the thymus and subsequent differentiation within the thymus. We found that in the absence of kindlin-3 a well-organized thymus with normal thymus architecture consisting of the four major compartments (subcapsular zone, cortex, medulla and cortico-medullary junction) is initially formed. The presence and clear separation of DP thymocytes in the cortex from SP CD4 and CD8 T cells in the medulla of postnatal thymi indicate that chemokine-driven migration and positioning of developing T cells to specialized thymic microdomains is not impaired in the absence of kindlin-3 allowing a well-orchestrated developmental maturation from T cell progenitors to mature T cells. Thus, our data indicate that chemokine sensing and leukocyte migration within a 3D environment can occur in the absence of kindlin-3´s role to regulate integrin activity, which is in line with a previous report (<xref ref-type="bibr" rid="bib22">Lämmermann et al., 2008</xref>).</p><p>While early thymic development is hardly affected by the lack of kindlin-3, the thymi from kindlin-3 deficient mice began shrinking after birth. We found two main reasons for the thymic atrophy. First, kindlin-3-deficient thymocytes exhibited reduced proliferation rates due to a weakened interaction with thymic APCs. A weakened interaction with APCs was also reported for CD4 T cells isolated from LFA-1 and talin-1 knockout mice to cause reduced T cell proliferation (<xref ref-type="bibr" rid="bib12">Graf et al., 2007</xref>; <xref ref-type="bibr" rid="bib15">Kandula and Abraham, 2004</xref>; <xref ref-type="bibr" rid="bib55">Wernimont et al., 2011</xref>).</p><p>Secondly, we observed a severe T cell progenitor homing defect, which becomes apparent at the end of embryogenesis. T cell development in the thymus requires a periodic homing of FL or BM-derived T cell progenitors. The trafficking routes taken by T cell progenitors to the thymus depend on the vascularisation state of the thymus. After vascularization at E15/E16 (<xref ref-type="bibr" rid="bib24">Liu et al., 2006</xref>), FL and later on BM-derived lymphoid progenitors directly enter the thymus at large post-capillary venules at the thymus cortico-medullary junction. This process is critically dependent on kindlin-3. Furthermore, our findings also show that kindlin-3-dependent adhesiveness through multiple integrin classes expressed on T lymphoid progenitors is essential for their homing to the vascularized thymus, while loss of individual integrins either did not or only partially diminish precursor T cell homing (<xref ref-type="bibr" rid="bib44">Scimone et al., 2006</xref>).</p><p>Our findings also revealed that kindlin-3-deficient T cell progenitors were able to colonize the non-vascularized thymus primordium and develop into SP CD4 and CD8 T cells that are released into the circulation and found in the spleen. Although early colonization of the thymus anlage was slightly delayed and less efficient, kindlin-3-deficient T cell progenitors were capable to leave the pharyngeal vessels and migrate through the mesenchymal tissue before they reach and enter the thymic anlage. The reduced homing performance of kindlin-3-deficient T cell progenitors was neither due to their reduced production in the FL and/or release into the circulation, nor due to a defect in sensing chemokine cues that direct them towards the thymic primordium. So, we assume that reduced adhesion to the pharyngeal vessel wall accounts for the mild T cell progenitor homing defect of kindlin-3-deficient embryos, an assumption, which is also supported by the accumulation of T cell progenitors in the embryonic circulation.</p><p>Why can T cell progenitors extravasate from pharyngeal vessels at early developmental stages but fail to do so from post-capillary venules at the cortico-medullary junction of the vascularized thymus? We cannot fully exclude that differences in the expression of other cell surface receptors, such as CD44 or selectin ligands, may exist between FL and BM-derived T cell progenitors, which allow kindlin-3/integrin independent adhesion and extravasation. However, since impaired adhesion and extravasation becomes evident already before E16, a time point at which BM-derived T cell progenitors have not formed yet, we do not believe that this can explain the homing defect. The fact that FL-derived T cell progenitors are initially capable but later fail to home to the thymus suggests that cell extrinsic rather than cell intrinsic factors are responsible for the impaired colonization. Differences in thymus vascularization might be an obvious possibility, especially since a previous report suggested kindin-3 expression in endothelial cells (<xref ref-type="bibr" rid="bib3">Bialkowska et al., 2010</xref>). However, we found normal vascularization of the thymus anlage in the absence of kindlin-3 and could show that thymic endothelial cells do not express kindlin-3. Since kindlin-3-deficient thymi exhibited a dramatic drop in the number of DN1 and DN2 cells between E15 to E16, which is the time point when the thymus becomes vascularized (<xref ref-type="bibr" rid="bib24">Liu et al., 2006</xref>), we suggest that differences in the adhesive properties of pharyngeal vs. intrathymic vessels account for this phenomenon. In support of this hypothesis, we reported that kindlin-3-deficient effector T cells can leave the brain vascular system during inflammation when the endothelium expresses ICAM-1 and VCAM-1 at high levels (<xref ref-type="bibr" rid="bib31">Moretti et al., 2013</xref>). Similarly, kindlin-3-deficient effector T cells cannot extravasate from inflamed dermal microvessels but are able to leave postcapillary venules of skin-draining inflamed lymph nodes, probably because the high expression of integrin ligands and P-selectin stabilizes the weak adhesions of kindlin-3-deficient T cells (<xref ref-type="bibr" rid="bib7">Cohen et al., 2013</xref>). However, expression of the integrin ligands ICAM-1/2 and VCAM-1 in pharyngeal vessels is lower than in intrathymic vessels thereby excluding this possibility. Therefore, we reasoned that another mechanism must be responsible for the homing ability of kindlin-3-deficient T cell progenitors to the early thymus.</p><p>Beside its role in triggering integrin activation in association with talin-1 (<xref ref-type="bibr" rid="bib26">Ma et al., 2008</xref>; <xref ref-type="bibr" rid="bib30">Montanez et al., 2008</xref>; <xref ref-type="bibr" rid="bib33">Moser et al., 2009a</xref>; <xref ref-type="bibr" rid="bib34">Moser et al., 2009b</xref>; <xref ref-type="bibr" rid="bib35">Moser et al., 2008</xref>), kindlin-3 is important in stabilizing integrin-ligand interactions by promoting integrin clustering (<xref ref-type="bibr" rid="bib9">Feng et al., 2012</xref>; <xref ref-type="bibr" rid="bib57">Ye et al., 2013</xref>). Thus, the gradual T cell progenitor homing defect observed in kindlin-3-deficient mice might be due to instable T cell progenitor/endothelial adhesions, which are unable to withstand increasing shear forces elicited by the maturing blood circulation. Using an intravital microscopy approach we indeed measured an increase in systemic blood flow velocities and shear rates leading to higher hemodynamic forces T-cell progenitors are exposed to during development. In addition, our flow chamber experiments with FL-derived T cell progenitors confirmed this as kindlin-3-deficient cells could adhere to VCAM-1 coated surfaces at low shear stress levels but readily detached at higher shear stress levels when compared to control cells. Moreover, T cells expressing very low kindin-3 levels predominantly adhere to LN vessel segments with lower shear rates than WT T cells. Thus, low shear force conditions may allow adhesion of kindlin-3-deficient T cell progenitors to fetal pharyngeal microvessels, hence enabling their extravasation. However with increasing shear forces at later time points during fetal life, T cell progenitors lacking kindlin-3 and therefore the ability to strengthening integrin-mediated adhesion are not able to efficiently adhere to and migrate out of microvessels into the thymus. The ability to resist low shear forces is also supported by an early report that found high expression of α4β1 on the surface of FL-derived T cell progenitors (<xref ref-type="bibr" rid="bib16">Kawakami et al., 1999</xref>). In addition, we and others have shown that α4β1-mediated adhesiveness to VCAM-1 is less affected by loss of kindlin-3 in contrast to αLβ2 integrin-mediated adhesion to ICAM-1 (<xref ref-type="bibr" rid="bib17">Klapproth et al., 2015</xref>; <xref ref-type="bibr" rid="bib28">Manevich-Mendelson et al., 2009</xref>; <xref ref-type="bibr" rid="bib31">Moretti et al., 2013</xref>). In this respect, it is interesting to note that lack of β1 integrin expression on hematopoietic stem cells (HSC) abolishes their extravasation and homing to the BM (<xref ref-type="bibr" rid="bib37">Potocnik et al., 2000</xref>), whereas kindlin-3-deficient HSCs revealed significantly diminished but not absent homing to the BM (<xref ref-type="bibr" rid="bib40">Ruppert et al., 2015</xref>).</p><p>Taken together, our work demonstrates that kindlin-3 is dispensable for integrin-mediated T cell adhesion and signalling at low and indispensable at high vascular shear forces. Furthermore, we also show a general, crucial role of integrins during T cell development and suggest an additional not yet investigated T cell phenotype in LADIII patients.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th><th>Additional information</th></tr></thead><tbody><tr><td>Genetic reagent <break/>(<italic>M.musculus</italic>)</td><td><italic>Fermt3<sup>-/-</sup></italic></td><td>PMID: 18278053</td><td>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:2147790">MGI:2147790</ext-link></td><td>Dr. Reinhard Fässler <break/>(Max Planck Institute <break/>of Biochemistry)</td></tr><tr><td>Genetic reagent <break/>(<italic>M.musculus</italic>)</td><td><italic>Fermt3<sup>flox</sup></italic></td><td>PMID: 24089451</td><td>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:5551978">MGI:5551978</ext-link></td><td>Dr. Reinhard Fässler <break/>(Max Planck Institute <break/>of Biochemistry)</td></tr><tr><td>Genetic reagent <break/>(<italic>M.musculus</italic>)</td><td><italic>Fermt3<sup>n/-</sup></italic></td><td>PMID: 26438512</td><td>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:3785479">MGI:3785479</ext-link></td><td>Dr. Reinhard Fässler <break/>(Max Planck Institute <break/>of Biochemistry)</td></tr><tr><td>Genetic reagent <break/>(<italic>M.musculus</italic>)</td><td><italic>Rag2<sup>-/-</sup></italic></td><td>PMID: 1547487</td><td>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:1858556">MGI:1858556</ext-link></td><td>Dr. Frederick W Alt <break/>(Howard Hughes <break/>Medical Institute)</td></tr><tr><td>Genetic reagent <break/>(<italic>M.musculus</italic>)</td><td><italic>Mx1-Cre</italic></td><td>PMID: 7660125</td><td>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:2176073">MGI:2176073</ext-link></td><td>Dr. Klaus Rajewsky <break/>(Max Delbrück Center <break/>for Molecular Medicine)</td></tr><tr><td>Genetic reagent <break/>(<italic>M.musculus</italic>)</td><td><italic>CD4-Cre</italic></td><td>PMID: 11728338</td><td>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI">MGI</ext-link>: 2386448</td><td>Dr. Christopher B. <break/>Wilson, (University <break/>of Washington)</td></tr><tr><td>Genetic reagent <break/>(<italic>M.musculus</italic>)</td><td><italic>2D2</italic></td><td>PMID: 12732654</td><td>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:3700794">MGI:3700794</ext-link></td><td>Dr. Vijay K Kuchroo <break/>(Center for Neurologic <break/>Diseases)</td></tr><tr><td>Genetic reagent <break/>(<italic>M.musculus</italic>)</td><td><italic>mTmG</italic></td><td>PMID: 17868096</td><td>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:3716464">MGI:3716464</ext-link></td><td>Dr. Liqun Luo <break/>(Howard Hughes <break/>Medical Institute)</td></tr><tr><td>Antibody</td><td>anti-B220-biotin</td><td>BD Pharmingen</td><td>Cat. #: 553085; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_394615">AB_394615</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>POD-coupled <break/>anti-BrdU</td><td>Roche</td><td>Cat. #: 11 585 860 001; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_514485">AB_514485</ext-link></td><td>IHC (1:30)</td></tr><tr><td>Antibody</td><td>rabbit anti-mouse <break/>cleaved caspase-3</td><td>Cell Signalling</td><td>Cat. #: 9661; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2341188">AB_2341188</ext-link></td><td>IHC (1:100)</td></tr><tr><td>Antibody</td><td>anti-CD3e</td><td>eBioscience</td><td>Cat. #: 14-0031-82; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_467049">AB_467049</ext-link></td><td>10 µg/ml</td></tr><tr><td>Antibody</td><td>anti-CD3e-biotin</td><td>BD Pharmingen</td><td>Cat. #: 553060; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_394593">AB_394593</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>anti-CD3-PE</td><td>BD Pharmingen</td><td>Cat. #: 555275; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_395699">AB_395699</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>anti-CD4-biotin</td><td>BD Pharmingen</td><td>Cat. #: 553649; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_394969">AB_394969</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>anti-CD4-FITC</td><td>BD Pharmingen</td><td>Cat. #: 553651; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_394971">AB_394971</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>anti-CD4-PerCP</td><td>BD Pharmingen</td><td>Cat. #: 550954; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_393977">AB_393977</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>anti-CD5-PE</td><td>eBioscience</td><td>Cat. #: 12-0051-82; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_465523">AB_465523</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>anti-CD8α-biotin</td><td>BD Pharmingen</td><td>Cat. #: 553028; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_394566">AB_394566</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>anti-CD8-APC</td><td>eBioscience</td><td>Cat. #: 17-0081-81; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_469334">AB_469334</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>anti-CD8-PE</td><td>eBioscience</td><td>Cat. #: 12-0081-81; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_465529">AB_465529</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>anti-CD11b-biotin</td><td>BD Pharmingen</td><td>Cat. #: 557395; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2296385">AB_2296385</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>anti-CD11c-biotin</td><td>BD Pharmingen</td><td>Cat. #: 553800; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_395059">AB_395059</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>anti-CD16/CD32</td><td>BD Pharmingen</td><td>Cat. #: 553142; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_394657">AB_394657</ext-link></td><td>FACS (1:400)</td></tr><tr><td>Antibody</td><td>anti-CD19-biotin</td><td>eBioscience</td><td>Cat. #: 13-0193-82; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_657656">AB_657656</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>anti-CD24-PE</td><td>BD Pharmingen</td><td>Cat. #: 553262; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_394741">AB_394741</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>anti-CD25-FITC</td><td>BD Pharmingen</td><td>Cat. #: 553071; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_394603">AB_394603</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>anti-CD28</td><td>eBioscience</td><td>Cat. #: 14-0281-82; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_467190">AB_467190</ext-link></td><td>2 µg/ml</td></tr><tr><td>Antibody</td><td>rat anti-CD31 (PECAM-1)</td><td>BD Pharmingen</td><td>Cat. #: 557355; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_396660">AB_396660</ext-link></td><td>IHC (1:300)</td></tr><tr><td>Antibody</td><td>anti-CD31- <break/>Alexa Fluor 647</td><td>Biolegend</td><td>Cat. #: 102415; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_493411">AB_493411</ext-link></td><td>IHC (1:200)</td></tr><tr><td>Antibody</td><td>anti-CD31-eFLour450</td><td>eBioscience</td><td>Cat. #: 48-0311-82; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10598807">AB_10598807</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>anti-CD44-PE</td><td>BD Pharmingen</td><td>Cat. #: 553134; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_394649">AB_394649</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>anti-CD45-FITC</td><td>eBioscience</td><td>Cat. #: 14-0451-82; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_467251">AB_467251</ext-link></td><td>IHC (1:100)</td></tr><tr><td>Antibody</td><td>anti-CD45.2-biotin</td><td>BD Pharmingen</td><td>Cat. #: 553771; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_395040">AB_395040</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>anti-CD45.2-APC</td><td>eBioscience</td><td>Cat. #: 17-0454-82; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_469400">AB_469400</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>hamster anti- <break/>CD54 (ICAM)</td><td>BD Pharmingen</td><td>Cat. #: 553250; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_394732">AB_394732</ext-link></td><td>IHC (1:100)</td></tr><tr><td>Antibody</td><td>goat anti- <break/>CD106 (VCAM)</td><td>R and D Systems</td><td>Cat. #: AF643; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_355499">AB_355499</ext-link></td><td>IHC (1:80)</td></tr><tr><td>Antibody</td><td>anti-c-kit-APC</td><td>eBioscience</td><td>Cat. #: 17-1171-81; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_469429">AB_469429</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>anti-c-kit-PerCP</td><td>Biolegend</td><td>Cat. #: 105821; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_893230">AB_893230</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>mouse anti-pan <break/>-cytokeratin</td><td>Sigma-Aldrich</td><td>Cat. #: C2562; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_476839">AB_476839</ext-link></td><td>IHC (1:400)</td></tr><tr><td>Antibody</td><td>anti-EpCAM-APC <break/>-eFlour780</td><td>Thermo Fisher Scientific</td><td>Cat. #: 47-5791-82; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2573986">AB_2573986</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>rat anti-ER-TR4</td><td>Eric Vroegindeweij <break/>(Princess Maxima <break/>center of pediatric <break/>oncology)</td><td/><td>IHC undiluted</td></tr><tr><td>Antibody</td><td>rat anti-ER-TR5</td><td>Eric Vroegindeweij <break/>(Princess Maxima <break/>center of pediatric <break/>oncology)</td><td/><td>IHC undiluted</td></tr><tr><td>Antibody</td><td>anti-F4/80-biotin</td><td>Bio-Rad</td><td>Cat. #: MCA497GA; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_323806">AB_323806</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>alexa-fluor-488- <break/>conjugated anti- <break/>Fluorescin IgG</td><td>Thermo Fisher <break/>Scientific</td><td>Cat. #: A-11090; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_221562">AB_221562</ext-link></td><td>IHC (1:500)</td></tr><tr><td>Antibody</td><td>rat anti-ICAM-1 PE</td><td>Biolegend</td><td>Cat. #:116107; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_313698">AB_313698</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>rabbit anti-Fibronectin</td><td>Merck Millipore</td><td>Cat. #: AB2033; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2105702">AB_2105702</ext-link></td><td>IHC (1:300)</td></tr><tr><td>Antibody</td><td>mouse anti-GAPDH</td><td>Merck Millipore</td><td>Cat. #: CB1001; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2107426">AB_2107426</ext-link></td><td>WB (1:20.000)</td></tr><tr><td>Antibody</td><td>anti-Gr-1-biotin</td><td>BD Pharmingen</td><td>Cat. #: 553125; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_394641">AB_394641</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>alexa-fluor-546 <break/>-conjugated <break/>anti-goat IgG</td><td>Thermo Fisher <break/>Scientific</td><td>Cat: #: A-11056; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2534103">AB_2534103</ext-link></td><td>IHC (1:300)</td></tr><tr><td>Antibody</td><td>alexa-fluor-546- <break/>conjugated <break/>anti-hamster IgG</td><td>Thermo Fisher <break/>Scientific</td><td>Cat: #: A-21111; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2535760">AB_2535760</ext-link></td><td>IHC (1:300)</td></tr><tr><td>Antibody</td><td>alexa-fluor-546- <break/>conjugated <break/>anti-mouse IgG</td><td>Thermo Fisher <break/>Scientific</td><td>Cat: #: A-11003; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2534071">AB_2534071</ext-link></td><td>IHC (1:300)</td></tr><tr><td>Antibody</td><td>alexa-fluor-647 <break/>-conjugated <break/>anti-mouse IgG</td><td>Thermo Fisher <break/>Scientific</td><td>Cat: #: A-31571; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_162542">AB_162542</ext-link></td><td>IHC (1:300)</td></tr><tr><td>Antibody</td><td>alexa-fluor-647 <break/>-conjugated <break/>anti-rabbit IgG</td><td>Thermo Fisher <break/>Scientific</td><td>Cat: #: A-21244; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2535812">AB_2535812</ext-link></td><td>IHC (1:300)</td></tr><tr><td>Antibody</td><td>alexa-fluor-488- <break/>conjugated <break/>anti-rat IgG</td><td>Thermo Fisher <break/>Scientific</td><td>Cat: #: A-11006; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2534074">AB_2534074</ext-link></td><td>IHC (1:300)</td></tr><tr><td>Antibody</td><td>alexa-fluor-647- <break/>conjugated <break/>anti-rat IgG</td><td>Thermo Fisher <break/>Scientific</td><td>Cat: #: A-21247; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_141778">AB_141778</ext-link></td><td>IHC (1:300)</td></tr><tr><td>Antibody</td><td>anti-Integrin α4-PE</td><td>BD Pharmingen</td><td>Cat. #: 553157; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_394670">AB_394670</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>anti-Integrin αL-PE</td><td>BD Pharmingen</td><td>Cat. #: 553121; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_394637">AB_394637</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>anti-Integrin β1-PE</td><td>Biolegend</td><td>Cat. #: 102207; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_312884">AB_312884</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>anti-Integrin β2-PE</td><td>BD Pharmingen</td><td>Cat. #: 553293; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_394762">AB_394762</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>anti-Integrin β3-PE</td><td>eBioscience</td><td>Cat. #: 12-0611-81; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_465717">AB_465717</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>anti-Integrin β7-PE</td><td>BD Pharmingen</td><td>Cat. #: 557498; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_396735">AB_396735</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>rabbit anti-Kindlin-1</td><td>Markus Moser <break/>(MPI of Biochemistry)</td><td/><td>WB (1:1000)</td></tr><tr><td>Antibody</td><td>mouse anti-Kindlin-2</td><td>Sigma-Aldrich</td><td>Cat. # SAB4200525 <break/>-200UL</td><td>WB (1:1000)</td></tr><tr><td>Antibody</td><td>rabbit anti-Kindlin-3</td><td>Markus Moser <break/>(MPI of Biochemistry)</td><td/><td>WB (1:3000)</td></tr><tr><td>Antibody</td><td>rabbit <break/>anti-pan-laminin</td><td>Rupert Timpl</td><td/><td>IHC (1:700)</td></tr><tr><td>Antibody</td><td>anti-LFA-1-PE</td><td>BD Pharmingen</td><td>Cat. #: 553121; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_394637">AB_394637</ext-link></td><td>IF (1:100)</td></tr><tr><td>Antibody</td><td>anti-NK1.1-biotin</td><td>BD Pharmingen</td><td>Cat. #: 553163; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_394675">AB_394675</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>anti-PIR-APC</td><td>eBioscience</td><td>Cat. #: 17-3101-82; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1944406">AB_1944406</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>anti-PIR-PE</td><td>BD Pharmingen</td><td>Cat. #: 550349; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_393628">AB_393628</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>anti-p-Tyrosine</td><td>Santa Cruz <break/>Biotechnology</td><td>Cat. #: sc-7020; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_628123">AB_628123</ext-link></td><td>IF (1:50)</td></tr><tr><td>Antibody</td><td>anti-Sca-1-PE</td><td>eBioscience</td><td>Cat. #: 12-5981-82; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_466086">AB_466086</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>mouse anti-talin</td><td>Sigma-Aldrich</td><td>Cat. #: T3287; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_477572">AB_477572</ext-link></td><td>WB (1:20.000)</td></tr><tr><td>Antibody</td><td>anti-TCRβ-PE</td><td>eBioscience</td><td>Cat. #: 12-5961-82; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_466066">AB_466066</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>anti-TCRγδ-biotin</td><td>BD Pharmingen</td><td>Cat. #: 553176; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_394687">AB_394687</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>anti-Ter119-biotin</td><td>BD Pharmingen</td><td>Cat. #: 553672; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_394985">AB_394985</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>anti-Thy1.2-biotin</td><td>BD Pharmingen</td><td>Cat. #: 553001; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_394540">AB_394540</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Antibody</td><td>rat anti-VCAM-1 PE</td><td>Biolegend</td><td>Cat. #: 105713; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1134166">AB_1134166</ext-link></td><td>FACS (1:200)</td></tr><tr><td>Peptide, <break/>recombinant protein</td><td>recombinant <break/>mouse CCL21</td><td>R and D Systems</td><td>Cat. #: 457–6C; <break/>Accession #: <break/>P84444.1</td><td/></tr><tr><td>Peptide, <break/>recombinant protein</td><td>recombinant <break/>mouse CCL25</td><td>R and D Systems</td><td>Cat. #: 481-TK; <break/>Accession #: <break/>O35903.1</td><td/></tr><tr><td>Peptide, <break/>recombinant protein</td><td>recombinant <break/>mouse ICAM-1-FC</td><td>R and D Systems</td><td>Cat. #: 796-IC; <break/>Accession #: Q3U8M7</td><td/></tr><tr><td>Peptide, <break/>recombinant protein</td><td>MOG35-55</td><td>MPI of <break/>Biochemistry, <break/>Core facility</td><td/><td/></tr><tr><td>Peptide, <break/>recombinant protein</td><td>recombinant <break/>mouse P-Selectin-FC</td><td>R and D Systems</td><td>Cat. #: 737-PS; <break/>Accession #: <break/>Q01102</td><td/></tr><tr><td>Peptide, <break/>recombinant protein</td><td>recombinant <break/>mouse VCAM-1-FC</td><td>R and D Systems</td><td>Cat. #: 643-VM; <break/>Accession #: <break/>CAA47989</td><td/></tr><tr><td>Commercial <break/>assay or kit</td><td>PE Annexin V <break/>Apoptosis <break/>Detection Kit</td><td>BD Biosciences</td><td>Cat. #: 559763</td><td/></tr><tr><td>Commercial <break/>assay or kit</td><td>BrdU Flow Kit</td><td>BD Pharmingen</td><td>Cat. #: 559619; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2617060">AB_2617060</ext-link></td><td/></tr><tr><td>Commercial <break/>assay or kit</td><td>anti-biotin <break/>MicroBeads</td><td>Miltenyi</td><td>Cat. #: 130-090-485; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_244365">AB_244365</ext-link></td><td/></tr><tr><td>Commercial <break/>assay or kit</td><td>CD4 T cell isolation <break/>kit</td><td>Miltenyi</td><td>Cat. #: 130-104-454</td><td/></tr><tr><td>Commercial <break/>assay or kit</td><td>Vectastain Elite ABC <break/>HRP Kit, rabbit IgG</td><td>VECTOR <break/>laboratories</td><td>Cat. #: PK-6101; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2336820">AB_2336820</ext-link></td><td/></tr><tr><td>Chemical <break/>compound, drug</td><td>CellTrace CFSE <break/>Cell Proliferation Kit</td><td>Thermo Fisher <break/>Scientific</td><td>Cat. #: C34554</td><td/></tr><tr><td>Chemical <break/>compound, drug</td><td>Collagenase D</td><td>Sigma-Aldrich</td><td>Cat. #: C0130</td><td>1 mg/ml</td></tr><tr><td>Chemical <break/>compound, drug</td><td>FITC-Dextran</td><td>Sigma-Aldrich</td><td>Cat. #: FD150S</td><td/></tr><tr><td>Chemical <break/>compound, drug</td><td>DNaseI</td><td>Sigma-Aldrich</td><td>Cat. #: D5025</td><td>100 U/ml</td></tr><tr><td>Chemical <break/>compound, drug</td><td>dGuo</td><td>Sigma-Aldrich</td><td>Cat. #: D0901</td><td>1.35 mM</td></tr><tr><td>Chemical <break/>compound, drug</td><td>CellTrace Far Red <break/>Cell Proliferation Kit</td><td>Thermo Fisher <break/>Scientific</td><td>Cat. #: C34564</td><td>1 µM</td></tr><tr><td>Chemical <break/>compound, drug</td><td>FluoSpheres 580/606</td><td>Thermo Fisher <break/>Scientific</td><td>Cat. #: F8821</td><td>1 µM</td></tr><tr><td>Chemical <break/>compound, drug</td><td>LPS</td><td>Sigma-Aldrich</td><td>Cat. #: L2654</td><td>1 mg/ml</td></tr><tr><td>Chemical <break/>compound, drug</td><td>poly-L-Lysine</td><td>Sigma-Aldrich</td><td>Cat. #: P8920</td><td>pure</td></tr><tr><td>Chemical <break/>compound, drug</td><td>Phalloidin Alexa350</td><td>Thermo Fisher <break/>Scientific</td><td>Cat. #: A22281</td><td>IF (1:40)</td></tr><tr><td>Chemical <break/>compound, drug</td><td>PureCol</td><td>Advanced BioMatrix</td><td>Cat. #: 5005–100 ML</td><td/></tr><tr><td>Chemical <break/>compound, drug</td><td>Streptavidin Cy3</td><td>Jackson Immuno <break/>Research</td><td>Cat. #: 016-160-084; <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2337244">AB_2337244</ext-link></td><td>FACS (1:400)</td></tr><tr><td>Chemical <break/>compound, drug</td><td>Streptavidin FITC</td><td>Thermo Fisher <break/>Scientific</td><td>Cat. #: SA10002</td><td>FACS (1:200)</td></tr><tr><td>Chemical <break/>compound, drug</td><td>Streptavidin PerCP-Cy5.5</td><td>BD Pharmingen</td><td>Cat. #: 551419</td><td>FACS (1:200)</td></tr><tr><td>Software, algorithm</td><td>ImageJ</td><td>National Institute <break/>of Health</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_003070">SCR_003070</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td>ImSpector Pro</td><td>LaVision <break/>BioTec GmbH</td><td/><td/></tr><tr><td>Software, algorithm</td><td>Photoshop</td><td>Adobe</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_014199">SCR_014199</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td>Slidebook 6.0.8 Software</td><td>Intelligant <break/>Imaging <break/>Innovations</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_014300">SCR_014300</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td>VirtualDub</td><td>GNU General <break/>Public License (GPL)</td><td/><td/></tr><tr><td>Other</td><td>Glass Bottom <break/>Microwell Dishes</td><td>MatTek Corporation</td><td>Cat. #: P35G-1.5–20 C</td><td/></tr><tr><td>Other</td><td>Ibidi flow chambers <break/>µ-Slide I 0.8 Luer IbiTreat</td><td>Ibidi</td><td>Cat. #: 80196</td><td/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Mice and chimeras</title><p><italic>Fermt3</italic><sup>-/-</sup> mice have been described previously (<xref ref-type="bibr" rid="bib35">Moser et al., 2008</xref>). All mice were from a mixed 129/SvJ x C57BL/6 background. FL cell chimeras were generated as previously described (<xref ref-type="bibr" rid="bib38">Prümmer and Fliedner, 1986</xref>; <xref ref-type="bibr" rid="bib49">Tulunay et al., 1975</xref>). Briefly, 5–6 × 10<sup>6</sup> cells from the FL of E14.5 embryos were injected into the tail vain of sub-lethally irradiated (1 × 6 Gy) <italic>Rag2</italic><sup>-/-</sup> mice (<xref ref-type="bibr" rid="bib45">Shinkai et al., 1992</xref>) and chimeras were analyzed 8 to 10 weeks later. Mixed FL cell chimeras were generated by injection of 5 × 10<sup>6</sup> E14.5 FL cells from WT or <italic>Fermt3</italic><sup>-/-</sup> embryos, respectively, which were mixed with E14.5 FL cells from congenic B6.SJL WT embryos in a 9:1 ratio, into lethally irradiated C57BL/6 mice (1 × 7 Gy and 1 × 6 Gy with 4 hr in between). Conditional <italic>Fermt3</italic> deletion was obtained upon two intraperitoneal injections of pI-pC (500 μg/mouse) (GE Healthcare) into <italic>Fermt3</italic><sup>fl/fl</sup>/<italic>Mx1-Cre</italic> mice. Pictures of dissected thymi were taken with a ProgRes C14 camera (JenOptic) connected to a Leica MZ FLIII stereomicroscope. All animals were mated and maintained under specific pathogen-free conditions at the animal facility of the Max Planck Institute of Biochemistry. All mouse experiments were performed with the approval of the District Government of Bavaria.</p></sec><sec id="s4-2"><title>Western blot analysis</title><p>Protein lysates were separated on a 10% SDS-PAGE and analyzed by Western blotting using polyclonal rabbit anti-mouse kindlin-1 and kindlin-3 antisera (<xref ref-type="bibr" rid="bib51">Ussar et al., 2008</xref>; <xref ref-type="bibr" rid="bib52">Ussar et al., 2006</xref>), monoclonal mouse anti-kindlin-2 (Sigma), monoclonal mouse anti-talin (Sigma) and mouse anti-GAPDH monoclonal antibody (Calbiochem) with a LAS-4000 imager (Fujifilm).</p></sec><sec id="s4-3"><title>Multi-color flow cytometry analysis and cell sorting</title><p>Multi-color flow-cytometric analysis and cell sorting were performed using FACS-Calibur and FACS-Aria flow cytometers (BD Biosciences), respectively. Data for viable cells, which were determined by forward light scatter and propidium iodide exclusion, were obtained with BD CellQuest Pro software. All antibodies we used were purchased from eBioscience or BD Pharmingen. Lineage negative (Lin<sup>neg</sup>) cell populations were obtained by removal of mature cells using the following cocktails of biotinylated antibodies: anti-B220, anti-CD19, anti-TER119, anti-NK1.1, anti-CD11b (Mac-1), anti-Gr-1, anti-CD8α, anti-CD3e, anti-TCRβ, anti-TCRγδ and anti-CD11c for fetal and adult thymi; anti-TER119, anti-B220, anti-CD11b, anti-Gr-1, anti-CD11c, anti-NK1.1, anti-CD4 and-CD8α for postnatal peripheral blood; anti-B220, anti-CD19, anti-TER119, anti-NK1.1, anti-Gr-1 and anti-Thy1.2 for FL and fetal blood (FB). Cells were then stained either with PerCP-Cy5.5-conjugated or FITC-coniugated Streptavidin and excluded by FL3 or FL1 FACS channels. The resulting Lin<sup>neg</sup> cell populations were further gated with anti-CD25-FITC, anti-CD44-PE and anti-c-kit-APC for thymocytes; with anti-Sca-1-PE and anti-c-kit-APC for postnatal peripheral blood cells; with anti-CD45-FITC, anti-PIR-PE and anti-c-kit-APC or anti-c-kit-PerCP, anti-PIR-APC and anti-integrin-PE (α4, αL, β1, β2, β3, β7) for FL cells; with anti-PIR-PE and anti-c-kit-APC for FB cells.</p><p>Mature T cells were analyzed for surface receptor expression with anti-CD4-FITC, anti CD8-APC, anti-CD3-PE, anti-CD5-PE, anti-CD24-PE and TCRβ-PE.</p><p>FL-Lin<sup>neg</sup> cells used for the time-lapse visualization of thymus attraction (see below) were obtained by negative selection through MACS separation columns with anti-Biotin-coupled magnetic beads according to the manufacturer’s instructions (MACS Miltenyi Biotec).</p><p>Expression of kindlin-3 in different thymic cell types was analysed by flow cytometry with thymi from Kindlin-3-EGFP knockin mice. A characterization of this mouse strain expressing a kindlin-3-EGFP fusion protein will be described elsewhere. In order to analyse kindlin-3 expression in leukocytes, thymic epithelial cells and endothelial cells, an adult thymus or a pool of 5 E15.5 fetal thymi were squeezed between two glass slides to remove the majority of T cells. The remaining tissue was digested in 1 mg/ml Collagenase D and 100 U/ml DNase I (both from Sigma) in 3% FCS/PBS for 20 to 30 min at 37°C, followed by a Fc-receptor block with anti-CD16/CD32 antibody and incubation with anti-CD31 eFlour450, anti-EpCAM APC eFlour780 (both Invitrogen), anti-CD45.2 APC and anti-CD3 PE antibodies.</p></sec><sec id="s4-4"><title>Immunofluorescence analysis of embryos and thymi</title><p>4% PFA-prefixed, frozen embryos and thymi embedded in Shandon Cryomatrix compound (Thermo Scientific) were first sliced into 8–10 μm thick sections and stained with the following antibodies for the embryos: rabbit anti-fibronectin polyclonal antibody (Chemicon), mouse anti-pan-cytokeratin monoclonal antibody (Sigma), rat anti-CD45-FITC (eBioscience), goat anti-CD106 (VCAM-1, R &amp; D Systems), hamster anti-CD54 (ICAM-1, Pharmingen) and rat anti-CD31 (PECAM-1, Pharmingen) followed by Alexa-Fluor-647-conjugated anti-rabbit IgG, Alexa-Fluor-546-conjugated anti-mouse IgG, Alexa-Fluor-488-conjugated anti-rat IgG, Alexa-Fluor-647-conjugated anti-mouse IgG, Alexa-Fluor-546-conjugated anti-goat IgG, and Fluor-546-conjugated anti-hamster IgG antibodies (Invitrogen); for the thymus: rabbit anti-pan-laminin polyclonal antibody (gift from Rupert Timpl), mouse anti-pan-cytokeratin monoclonal antibody (Sigma), rat anti-CD31 (PECAM-1, Pharmingen), rat anti-CD4-FITC (eBioscience), rat anti-CD8-Biotin (eBioscience), anti-CD106 (VCAM-1, R &amp; D Systems), hamster anti-CD54 (ICAM-1, Pharmingen), rat anti-ER-TR4 and anti-ER-TR5 polyclonal antibodies (kindly provided by Eric Vroegindeweij) followed by Alexa-Fluor-647-conjugated anti-rabbit IgG, Alexa-Fluor-647-conjugated anti-rat IgG, Alexa-Fluor-488-conjugated anti-Fluorescein/Oregon green IgG, Cy3-coniugated Streptavidin (Jackson), Alexa-Fluor-488-conjugated anti-rat IgG, Fluor-546-conjugated anti-goat IgG, and Fluor-546-conjugated anti-hamster IgG antibodies (Invitrogen). Thymic sections were fixed with acetone instead of PFA for anti-ER-TR4 and -TR5 staining.</p><p>Relative quantification of ICAM-1 and VCAM-1 expression was performed with directly labelled antibodies: rat anti-ICAM-1-PE, rat anti-VCAM-1-PE and the respective isotypes, rat anti-CD31-Alexa-Fluor 647 (all from Biolegend).</p><p>The stained sections were mounted with a fluorescence mounting medium (Elvanol) and images were acquired with a fluorescence microscope (Imager.Z1, Zeiss) and analyzed by the Axio Vision 40 (version 4.8.2.0) software (Zeiss), utilizing 10x, 20x and 40x magnifications.</p></sec><sec id="s4-5"><title>Immunohistologic analysis of the thymus</title><p>4% PFA fixed and paraffin-embedded thymi were sliced into 8 μm tick sections and stained with antibodies. The sections were counterstained with Mayer’s haematoxylin (Merck) and mounted in Entellan (Merck). Haematoxylin and Eosin (H/E) staining was performed according to standard protocol. Images were acquired with the light microscope Axioskop (Zeiss) and analyzed with the Adobe Photoshop software.</p></sec><sec id="s4-6"><title>Apoptosis assays</title><p>Paraffin-embedded thymus sections were stained with rabbit anti-mouse cleaved caspase-3 antibody (Cell Signalling). Apoptotic cells were detected by DAB staining after treatment with the immunoperoxidase Vectastain ABC system (Vector Laboratories).</p><p>Thymocytes from P3 mice were stained with PE-labeled Annexin V and 7-AAD according to the manufacturer’s instructions (BD Pharmingen Apoptosis Detection Kit). T cells were additionally stained for anti-CD4-FITC and anti-CD8-APC and analysed by FACS.</p></sec><sec id="s4-7"><title>Immune synapse analysis</title><p>CD4 T cells were purified from spleen by negative selection using biotinylated anti-CD8, anti-B220, anti-Gr-1, anti-F4/80 and anti-Ter119 antibodies and anti-biotin microbeads following the manufacturer´s instructions (MACS Miltenyi Biotec). Bone marrow derived, LPS matured dendritic cells were loaded with 1 µg/ml MOG35-55 peptide for 2 hr at a concentration of 10<sup>6</sup> cell/ml. 1 × 10<sup>5</sup> loaded DCs were mixed with 5 × 10<sup>5</sup> CD4 T cells in 200 µl R10 medium and seeded on poly-L-Lysine coated glass-bottom dishes (Mattek). Cells were fixed after 30 min by adding 200 µl warm 6% PFA in R10 medium for 20 min at 37°C. After permeabilization with 0.2% Triton X-100 in PBS for 15 min and blocking with 1% BSA for 1 h cells were stained with antibodies against LFA-1 (clone 2D7, BD Biosciences) and p-Tyrosine (PY199, Santa Cruz Biotechnology). Phalloidin Alexa350 was used to visualize actin. Cells were imaged with a Leica TCS SP5 X confocal microscope (Leica Microsystems) equipped with a 63 × NA 1.40 oil objective and Leica Confocal Software (LAS AF). Single channels were imaged sequentially. All pictures were processed with Photoshop (Adobe Systems, San José, California, USA).</p></sec><sec id="s4-8"><title>Proliferation assays</title><p>For in vivo labelling of thymocytes, bromodeoxyuridine (BrdU; 50 μg/gram body weight) was intraperitoneally injected into P3 mice. One hour after injection, cells were isolated from thymi and stained with FITC-labeled anti-BrdU monoclonal antibody (BD Pharmingen BrdU Flow Kit), anti-CD4-PerCP and anti-CD8-PE antibodies, and analyzed by flow cytometry. Alternatively, paraffin-embedded thymus sections were DAB stained after incubation with a POD-coupled anti-BrdU antibody (Roche).</p><p>For the in vitro labeling of control (WT/<italic>2D2</italic>) and kindlin-3-deficient (<italic>Fermt3</italic><sup>-/-</sup>/<italic>CD4-Cre/2D2</italic>) CD4<sup>+</sup> T cells (<xref ref-type="bibr" rid="bib31">Moretti et al., 2013</xref>), CellTrace CFSE Cell Proliferation Kit (Thermo Fisher) was used to trace dividing cells. Briefly, single cell suspensions from spleens were treated with ammonium-chloridepotassium for RBC lysis and CD4 T cells were sorted using CD4 T cell isolation kit (Milteniy Biotech). T cells were then stained with CFSE according to the manufacturer’s instructions and about 5 × 10<sup>4</sup> T cells per sample were cocultured in triplicate in 96-well round bottom plate with 2 × 10<sup>4</sup> DCs and increasing concentration of soluble MOG35-55 peptide (0.1, 1 and 10 μg/mL). For T cell stimulation with anti-CD3e and anti-CD28 Abs, 2 × 10<sup>5</sup> CFSE-labelled cells per sample were cultured in wells pre-coated for 1 hr at 37°C with anti-CD3e (10 µg/ml, eBioscience), with soluble anti-CD28 (2 µg/ml, eBioscience) and PMA (20 ng/ml). Proliferation was analysed by FACS after 3 days of incubation in R10 (RPMI-1640, 10% FCS, 1x Penicillin-Streptomycin) at 37°C.</p></sec><sec id="s4-9"><title>Time-lapse visualization of thymus attraction</title><p>Time-lapse imaging of horizontal cell migration to fetal thymus lobes was recorded as previously described (<xref ref-type="bibr" rid="bib25">Liu et al., 2005</xref>; <xref ref-type="bibr" rid="bib50">Ueno et al., 2005</xref>). Briefly, 10 µL of freshly neutralized collagen solution (1.72 mg/mL PureCol, Advanced BioMatrix, in RPMI 1640-based culture medium) containing 1–2 × 10<sup>5</sup> FL-Lin<sup>neg</sup> cells from either <italic>Fermt3</italic><sup>+/+</sup> or <italic>Fermt3</italic><sup>-/-</sup> C57BL/6 (CD45.2<sup>+</sup>) animals was placed in a 35 mm plastic dish and solidified at 37°C for 10 min. An E15.5 fetal thymus lobe from wild-type SJL (CD45.1<sup>+</sup>) mouse, pre-treated for 6 days with 1.35 mM 2-deoxyguanosine (dGuo; Sigma) was positioned approximately 0.5 mm away from the cell spot. The culture was submerged in 1.72 mg/mL collagen medium and solidified at 37°C for 30 min. The dish was placed in 5% CO<sub>2</sub> under an Axiovert 40 CFL microscope (Zeiss) equipped with a digital CCD camera. The culture was time-lapse monitored for 36 to 48 hr. After colonization, fetal thymus lobes were removed from the collagen gel, rinsed, and further cultured for 18 days under conventional organ culture conditions (see below). Thymi were than pooled, squeezed through a cell strainer and the resulting single cell suspensions were stained with anti-CD45.2 to identify FL cell-derived thymocytes and further gated for anti-CD4-FITC and anti-CD8-APC.</p></sec><sec id="s4-10"><title>Fetal Thymus Organ Culture</title><p>Seeded thymus lobes were cultured on 0.8 μm isopore membrane filters (Millipore) supported by a Gelfoam sponge (Pfizer) at an interface between 5% CO<sub>2</sub>-humidified air and RPMI 1640-based culture medium containing 10% FCS, 100 U/ml penicillin and 100 μg/ml streptomycin (PAA), 2 mM L-glutamine (PAA), 1X non-essential amino acids (Gibco), 1 mM sodium pyruvate (Gibco), 10 mM HEPES, 50 μM 2-mercaptoethanol (Sigma). Details have been described (<xref ref-type="bibr" rid="bib50">Ueno et al., 2005</xref>).</p></sec><sec id="s4-11"><title>Blood flow velocity measurement</title><p>Blood flow velocity measurements were performed in the fetal yolk-sac vasculature of E12.5 to E16.5 fetuses as described (<xref ref-type="bibr" rid="bib29">Margraf et al., 2017</xref>). Briefly, pregnant WT mice were anesthetised and fetuses surrounded by the yolk sac and still connected to the placenta were surgically exteriorized and placed on a modified intravital microscopy stage. Manually prepared glass microcapillaries (Clark Capillaries GCI150TF-10, Clark Electromedical Instruments, Pangbourne Reading) were used to inject 4 µl of a 5% FITC dextrane solution (FD150S, Sigma-Aldrich, Taufkirchen, Germany) with 1 µl of red fluorescent microspheres (FluoSpheres polystyrene microspheres 1,0 µm red fluorescent 580/605; Invitrogen) into the fetal vasculature. Imaging was performed using an in vivo microscope setup (Olympus BX1, Olympus, Hamburg, Germany) equipped with appropriate filter sets and a double-flash device (Rapp Optoelectronics, Hamburg, Germany). Images were recorded using a 60x objective (Olympus LUM Plan FI/IR 60x/0.90W) with setup specific CCD-cameras (Kappa CF5 HS; Kappa Optronics GmbH, Gleichen, Germany, and LaVision Imager ProX pco.1600L, LaVision GmbH, Goettingen, Germany) and recorded utilizing VirtualDub (<ext-link ext-link-type="uri" xlink:href="http://www.virtualdub.org">www.virtualdub.org</ext-link>) and Imspector Pro Software (Lavision BioTec GmbH, Bielefeld, Germany). Analysis was performed using ImageJ (National Institute of Health). Vessel diameters were chosen between 20 and 50 µm.</p></sec><sec id="s4-12"><title>Flow chamber assays</title><p>Flow chamber assays were performed with the ibidi pump system (Martinsried, Germany). Ibidi flow chambers (µ-Slide I 0.8 Luer ibiTreat) were coated with 10 µg/ml recombinant mouse (rm) ICAM-1-Fc or rmVCAM-1-Fc, 10 µg/ml rmP-selectin-Fc, 5 µg/ml rmCCL21 and 5 µg/ml rmCCL25 (all from R &amp; D systems) over night at 4°C. After blocking for 1 hr with 1% casein (Thermo Fisher Scientific) at room temperature, the channels were filled with control or <italic>Fermt3<sup>-/-</sup></italic> Pir<sup>+</sup> T cell progenitors sorted from E13.5 fetal livers. After 3 min incubation without flow, slow flow of approximately 0.15 dyn/cm<sup>2</sup> was applied for 3 min followed by increasing flow of 1 and 3 dyn/cm<sup>2</sup> for 10 min each. Pictures were taken every 5 s for a total of 25 min at an Axiovert 40 CFL microscope (Zeiss) equipped with a digital CCD camera and a 10 x objective. The number of cells that were adherent immediately before the start of the fast flow was set to 100%. Cells that did not change position within 10 s were considered to be firmly adherent.</p></sec><sec id="s4-13"><title>Live cell imaging of T cell adhesion within the lymph node vasculature and flow in vivo</title><p>CD4 T cells were isolated from spleen by negative selection as described above. Anaesthetized mice were injected intravenously with a 1:1 mixture of CFSE and Far Red labelled WT and <italic>Fermt3</italic> hypomorphic CD4 T cells. The hair of the hind legs was removed and mice were placed into an imaging chamber with integrated heating plate. In a dorsal approach the skin of the hind legs was cut and the popliteal lymph nodes were exposed. To reveal the superficial vessels of the lymph nodes, they were fixed to the biceps femoris muscle using Histoacryl tissue adhesive (B. Braun). PBS-soaked batting was placed around the legs to keep the tissue moist. The lymph nodes were covered with a cover glass, which was topped with PBS to facilitate imaging. Time-lapse video microscopy was performed using an upright spinning disk confocal microscope (Examiner, Zeiss, Germany) equipped with a confocal scanner unit CSU-X1 (Yokogawa Electric Corporation, Japan), an EMCCD camera (Evolve, Photometrics, USA) and a 20x/1.0NA water immersion objective (Zeiss, Germany). 4D images (30 z-stacks with a step size of 4 µm and an average time lapse interval of 42 s) were acquired by using two lasers with an excitation wavelength of 488 nm and 640 nm. Adhesion was analyzed by generating sum projections of z-stacks over time using Slidebook 6.0.8 Software (3i, USA). The number of adherent leukocytes was determined as cells attached to the same position for more than 1 min using Fiji/ImageJ software (NIH, USA). Centerline blood flow velocities in the same vessels were obtained upon subsequent intravenous injection of 10<sup>7</sup> fluorescent microspheres (1 µm in diameter; FluoSpheres 580/605, Invitrogen) by measuring frame‐to-frame displacement of single beads in LN microvessel segments. Images of one plane with an average time lapse interval of 66.5 ms were acquired for one minute using one laser with an excitation wavelength of 561 nm. Wall shear rates were calculated as previously described (<xref ref-type="bibr" rid="bib47">Sperandio et al., 2006</xref>).</p></sec><sec id="s4-14"><title>Statistic analysis</title><p>Means, standard deviations and statistical comparisons with Student’s t-test (*p&lt;0.05, **p&lt;0.01, ***p&lt;0.001) were made using Microsoft Excel software.</p></sec></sec></body><back><ack id="ack"><title>Ackowledgments</title><p>We thank Arnoud Sonnenberg for critically reading the manuscript and the Fässler lab members for discussion, Michal Grzejszczyk and Kerstin Kraus for excellent technical assistance and Eric Vroegindeweij for providing the anti-ER-TR4 and 5 antibodies. The work was supported by the Deutsche Forschungsgemeinschaft (SFB914; Projects A01, A05, B01, B09 and Z03) and the Max Planck Society.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf2"><p>Reviewing editor, <italic>eLife</italic></p></fn><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Investigation, Writing—original draft, Carried out most experiments and data analyses, Evaluated and interpreted the data</p></fn><fn fn-type="con" id="con2"><p>Investigation, Carried out most experiments and data analyses, Evaluated and interpreted the data</p></fn><fn fn-type="con" id="con3"><p>Investigation, Generated and analysed chimeric mice</p></fn><fn fn-type="con" id="con4"><p>Investigation, Measured blood flow velocities and shear rates in the yolk sac vasculature</p></fn><fn fn-type="con" id="con5"><p>Investigation, Performed and analysed the lymph node homing experiments</p></fn><fn fn-type="con" id="con6"><p>Investigation, Performed and analysed the lymph node homing experiments</p></fn><fn fn-type="con" id="con7"><p>Supervision, Investigation, Supervised the lymph node homing experiments and measured integrin ligand expression in the vasculature</p></fn><fn fn-type="con" id="con8"><p>Supervision, Supervised the blood flow and shear rate measurements in the yolk sac vasculature</p></fn><fn fn-type="con" id="con9"><p>Supervision, Funding acquisition, Writing—review and editing</p></fn><fn fn-type="con" id="con10"><p>Supervision, Funding acquisition, Investigation, Writing—original draft, Writing—review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Animal experimentation: Housing and use of laboratory animals at the Max Planck Institute of Biochemistry are fully compliant with all German (e.g. German Animal Welfare Act) and EU (e.g. Annex III of Directive 2010/63/EU on the protection of animals used for scientific purposes) applicable laws and regulations concerning care and use of laboratory animals. All of the animals were handled according to approved licenses from the Government of Upper Bavaria (55.2-1-54-2532-96-2015 and 55.2-1-54-2532-175-2011)</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><object-id pub-id-type="doi">10.7554/eLife.35816.018</object-id><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-35816-transrepform-v2.pdf"/></supplementary-material><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p></sec></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arroyo</surname> <given-names>AG</given-names></name><name><surname>Yang</surname> <given-names>JT</given-names></name><name><surname>Rayburn</surname> <given-names>H</given-names></name><name><surname>Hynes</surname> <given-names>RO</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Differential requirements for alpha4 integrins during fetal and adult hematopoiesis</article-title><source>Cell</source><volume>85</volume><fpage>997</fpage><lpage>1008</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)81301-X</pub-id><pub-id pub-id-type="pmid">8674127</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bettelli</surname> <given-names>E</given-names></name><name><surname>Pagany</surname> <given-names>M</given-names></name><name><surname>Weiner</surname> <given-names>HL</given-names></name><name><surname>Linington</surname> <given-names>C</given-names></name><name><surname>Sobel</surname> <given-names>RA</given-names></name><name><surname>Kuchroo</surname> <given-names>VK</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis</article-title><source>The Journal of Experimental Medicine</source><volume>197</volume><fpage>1073</fpage><lpage>1081</lpage><pub-id pub-id-type="doi">10.1084/jem.20021603</pub-id><pub-id pub-id-type="pmid">12732654</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bialkowska</surname> <given-names>K</given-names></name><name><surname>Ma</surname> <given-names>YQ</given-names></name><name><surname>Bledzka</surname> <given-names>K</given-names></name><name><surname>Sossey-Alaoui</surname> <given-names>K</given-names></name><name><surname>Izem</surname> <given-names>L</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Malinin</surname> <given-names>N</given-names></name><name><surname>Qin</surname> <given-names>J</given-names></name><name><surname>Byzova</surname> <given-names>T</given-names></name><name><surname>Plow</surname> <given-names>EF</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The integrin co-activator Kindlin-3 is expressed and functional in a non-hematopoietic cell, the endothelial cell</article-title><source>Journal of Biological Chemistry</source><volume>285</volume><fpage>18640</fpage><lpage>18649</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.085746</pub-id><pub-id pub-id-type="pmid">20378539</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boehm</surname> <given-names>T</given-names></name><name><surname>Bleul</surname> <given-names>CC</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Thymus-homing precursors and the thymic microenvironment</article-title><source>Trends in Immunology</source><volume>27</volume><fpage>477</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.1016/j.it.2006.08.004</pub-id><pub-id pub-id-type="pmid">16920024</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bungartz</surname> <given-names>G</given-names></name><name><surname>Stiller</surname> <given-names>S</given-names></name><name><surname>Bauer</surname> <given-names>M</given-names></name><name><surname>Müller</surname> <given-names>W</given-names></name><name><surname>Schippers</surname> <given-names>A</given-names></name><name><surname>Wagner</surname> <given-names>N</given-names></name><name><surname>Fässler</surname> <given-names>R</given-names></name><name><surname>Brakebusch</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Adult murine hematopoiesis can proceed without beta1 and beta7 integrins</article-title><source>Blood</source><volume>108</volume><fpage>1857</fpage><lpage>1864</lpage><pub-id pub-id-type="doi">10.1182/blood-2005-10-007658</pub-id><pub-id pub-id-type="pmid">16735603</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname> <given-names>AQ</given-names></name><name><surname>Landman</surname> <given-names>KA</given-names></name><name><surname>Hughes</surname> <given-names>BD</given-names></name><name><surname>Witt</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>T cell development in the thymus: from periodic seeding to constant output</article-title><source>Journal of Theoretical Biology</source><volume>249</volume><fpage>384</fpage><lpage>394</lpage><pub-id pub-id-type="doi">10.1016/j.jtbi.2007.07.028</pub-id><pub-id pub-id-type="pmid">17869276</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname> <given-names>SJ</given-names></name><name><surname>Gurevich</surname> <given-names>I</given-names></name><name><surname>Feigelson</surname> <given-names>SW</given-names></name><name><surname>Petrovich</surname> <given-names>E</given-names></name><name><surname>Moser</surname> <given-names>M</given-names></name><name><surname>Shakhar</surname> <given-names>G</given-names></name><name><surname>Fassler</surname> <given-names>R</given-names></name><name><surname>Alon</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The integrin coactivator Kindlin-3 is not required for lymphocyte diapedesis</article-title><source>Blood</source><volume>122</volume><fpage>2609</fpage><lpage>2617</lpage><pub-id pub-id-type="doi">10.1182/blood-2013-04-495036</pub-id><pub-id pub-id-type="pmid">23980064</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Douagi</surname> <given-names>I</given-names></name><name><surname>André</surname> <given-names>I</given-names></name><name><surname>Ferraz</surname> <given-names>JC</given-names></name><name><surname>Cumano</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Characterization of T cell precursor activity in the murine fetal thymus: evidence for an input of T cell precursors between days 12 and 14 of gestation</article-title><source>European Journal of Immunology</source><volume>30</volume><fpage>2201</fpage><lpage>2210</lpage><pub-id pub-id-type="doi">10.1002/1521-4141(2000)30:18&lt;2201::AID-IMMU2201&gt;3.0.CO;2-J</pub-id><pub-id pub-id-type="pmid">10940911</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname> <given-names>C</given-names></name><name><surname>Li</surname> <given-names>YF</given-names></name><name><surname>Yau</surname> <given-names>YH</given-names></name><name><surname>Lee</surname> <given-names>HS</given-names></name><name><surname>Tang</surname> <given-names>XY</given-names></name><name><surname>Xue</surname> <given-names>ZH</given-names></name><name><surname>Zhou</surname> <given-names>YC</given-names></name><name><surname>Lim</surname> <given-names>WM</given-names></name><name><surname>Cornvik</surname> <given-names>TC</given-names></name><name><surname>Ruedl</surname> <given-names>C</given-names></name><name><surname>Shochat</surname> <given-names>SG</given-names></name><name><surname>Tan</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Kindlin-3 mediates integrin αLβ2 outside-in signaling, and it interacts with scaffold protein receptor for activated-C kinase 1 (RACK1)</article-title><source>Journal of Biological Chemistry</source><volume>287</volume><fpage>10714</fpage><lpage>10726</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.299594</pub-id><pub-id pub-id-type="pmid">22334666</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foss</surname> <given-names>DL</given-names></name><name><surname>Donskoy</surname> <given-names>E</given-names></name><name><surname>Goldschneider</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>The importation of hematogenous precursors by the thymus is a gated phenomenon in normal adult mice</article-title><source>The Journal of Experimental Medicine</source><volume>193</volume><fpage>365</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1084/jem.193.3.365</pub-id><pub-id pub-id-type="pmid">11157056</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Georges-Labouesse</surname> <given-names>E</given-names></name><name><surname>Messaddeq</surname> <given-names>N</given-names></name><name><surname>Yehia</surname> <given-names>G</given-names></name><name><surname>Cadalbert</surname> <given-names>L</given-names></name><name><surname>Dierich</surname> <given-names>A</given-names></name><name><surname>Le Meur</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Absence of integrin alpha 6 leads to epidermolysis bullosa and neonatal death in mice</article-title><source>Nature Genetics</source><volume>13</volume><fpage>370</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1038/ng0796-370</pub-id><pub-id pub-id-type="pmid">8673141</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graf</surname> <given-names>B</given-names></name><name><surname>Bushnell</surname> <given-names>T</given-names></name><name><surname>Miller</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>LFA-1-mediated T cell costimulation through increased localization of TCR/class II complexes to the central supramolecular activation cluster and exclusion of CD45 from the immunological synapse</article-title><source>The Journal of Immunology</source><volume>179</volume><fpage>1616</fpage><lpage>1624</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.179.3.1616</pub-id><pub-id pub-id-type="pmid">17641028</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Itoi</surname> <given-names>M</given-names></name><name><surname>Kawamoto</surname> <given-names>H</given-names></name><name><surname>Katsura</surname> <given-names>Y</given-names></name><name><surname>Amagai</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Two distinct steps of immigration of hematopoietic progenitors into the early thymus anlage</article-title><source>International Immunology</source><volume>13</volume><fpage>1203</fpage><lpage>1211</lpage><pub-id pub-id-type="doi">10.1093/intimm/13.9.1203</pub-id><pub-id pub-id-type="pmid">11526101</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jotereau</surname> <given-names>F</given-names></name><name><surname>Heuze</surname> <given-names>F</given-names></name><name><surname>Salomon-Vie</surname> <given-names>V</given-names></name><name><surname>Gascan</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>Cell kinetics in the fetal mouse thymus: precursor cell input, proliferation, and emigration</article-title><source>Journal of Immunology</source><volume>138</volume><fpage>1026</fpage><lpage>1030</lpage><pub-id pub-id-type="pmid">2879866</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kandula</surname> <given-names>S</given-names></name><name><surname>Abraham</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>LFA-1 on CD4+ T cells is required for optimal antigen-dependent activation in vivo</article-title><source>The Journal of Immunology</source><volume>173</volume><fpage>4443</fpage><lpage>4451</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.173.7.4443</pub-id><pub-id pub-id-type="pmid">15383575</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawakami</surname> <given-names>N</given-names></name><name><surname>Nishizawa</surname> <given-names>F</given-names></name><name><surname>Sakane</surname> <given-names>N</given-names></name><name><surname>Iwao</surname> <given-names>M</given-names></name><name><surname>Tsujikawa</surname> <given-names>K</given-names></name><name><surname>Ikawa</surname> <given-names>M</given-names></name><name><surname>Okabe</surname> <given-names>M</given-names></name><name><surname>Yamamoto</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Roles of integrins and CD44 on the adhesion and migration of fetal liver cells to the fetal Thymus</article-title><source>Journal of Immunology</source><volume>163</volume><fpage>3211</fpage><lpage>3216</lpage></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klapproth</surname> <given-names>S</given-names></name><name><surname>Moretti</surname> <given-names>FA</given-names></name><name><surname>Zeiler</surname> <given-names>M</given-names></name><name><surname>Ruppert</surname> <given-names>R</given-names></name><name><surname>Breithaupt</surname> <given-names>U</given-names></name><name><surname>Mueller</surname> <given-names>S</given-names></name><name><surname>Haas</surname> <given-names>R</given-names></name><name><surname>Mann</surname> <given-names>M</given-names></name><name><surname>Sperandio</surname> <given-names>M</given-names></name><name><surname>Fässler</surname> <given-names>R</given-names></name><name><surname>Moser</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Minimal amounts of kindlin-3 suffice for basal platelet and leukocyte functions in mice</article-title><source>Blood</source><volume>126</volume><fpage>2592</fpage><lpage>2600</lpage><pub-id pub-id-type="doi">10.1182/blood-2015-04-639310</pub-id><pub-id pub-id-type="pmid">26438512</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koch</surname> <given-names>U</given-names></name><name><surname>Radtke</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Mechanisms of T cell development and transformation</article-title><source>Annual Review of Cell and Developmental Biology</source><volume>27</volume><fpage>539</fpage><lpage>562</lpage><pub-id pub-id-type="doi">10.1146/annurev-cellbio-092910-154008</pub-id><pub-id pub-id-type="pmid">21740230</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koni</surname> <given-names>PA</given-names></name><name><surname>Joshi</surname> <given-names>SK</given-names></name><name><surname>Temann</surname> <given-names>UA</given-names></name><name><surname>Olson</surname> <given-names>D</given-names></name><name><surname>Burkly</surname> <given-names>L</given-names></name><name><surname>Flavell</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow</article-title><source>The Journal of experimental medicine</source><volume>193</volume><fpage>741</fpage><lpage>754</lpage><pub-id pub-id-type="pmid">11257140</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krüger</surname> <given-names>M</given-names></name><name><surname>Moser</surname> <given-names>M</given-names></name><name><surname>Ussar</surname> <given-names>S</given-names></name><name><surname>Thievessen</surname> <given-names>I</given-names></name><name><surname>Luber</surname> <given-names>CA</given-names></name><name><surname>Forner</surname> <given-names>F</given-names></name><name><surname>Schmidt</surname> <given-names>S</given-names></name><name><surname>Zanivan</surname> <given-names>S</given-names></name><name><surname>Fässler</surname> <given-names>R</given-names></name><name><surname>Mann</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>SILAC mouse for quantitative proteomics uncovers kindlin-3 as an essential factor for red blood cell function</article-title><source>Cell</source><volume>134</volume><fpage>353</fpage><lpage>364</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.05.033</pub-id><pub-id pub-id-type="pmid">18662549</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuijpers</surname> <given-names>TW</given-names></name><name><surname>van de Vijver</surname> <given-names>E</given-names></name><name><surname>Weterman</surname> <given-names>MA</given-names></name><name><surname>de Boer</surname> <given-names>M</given-names></name><name><surname>Tool</surname> <given-names>AT</given-names></name><name><surname>van den Berg</surname> <given-names>TK</given-names></name><name><surname>Moser</surname> <given-names>M</given-names></name><name><surname>Jakobs</surname> <given-names>ME</given-names></name><name><surname>Seeger</surname> <given-names>K</given-names></name><name><surname>Sanal</surname> <given-names>O</given-names></name><name><surname>Unal</surname> <given-names>S</given-names></name><name><surname>Cetin</surname> <given-names>M</given-names></name><name><surname>Roos</surname> <given-names>D</given-names></name><name><surname>Verhoeven</surname> <given-names>AJ</given-names></name><name><surname>Baas</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>LAD-1/variant syndrome is caused by mutations in FERMT3</article-title><source>Blood</source><volume>113</volume><fpage>4740</fpage><lpage>4746</lpage><pub-id pub-id-type="doi">10.1182/blood-2008-10-182154</pub-id><pub-id pub-id-type="pmid">19064721</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lämmermann</surname> <given-names>T</given-names></name><name><surname>Bader</surname> <given-names>BL</given-names></name><name><surname>Monkley</surname> <given-names>SJ</given-names></name><name><surname>Worbs</surname> <given-names>T</given-names></name><name><surname>Wedlich-Söldner</surname> <given-names>R</given-names></name><name><surname>Hirsch</surname> <given-names>K</given-names></name><name><surname>Keller</surname> <given-names>M</given-names></name><name><surname>Förster</surname> <given-names>R</given-names></name><name><surname>Critchley</surname> <given-names>DR</given-names></name><name><surname>Fässler</surname> <given-names>R</given-names></name><name><surname>Sixt</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Rapid leukocyte migration by integrin-independent flowing and squeezing</article-title><source>Nature</source><volume>453</volume><fpage>51</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1038/nature06887</pub-id><pub-id pub-id-type="pmid">18451854</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ley</surname> <given-names>K</given-names></name><name><surname>Laudanna</surname> <given-names>C</given-names></name><name><surname>Cybulsky</surname> <given-names>MI</given-names></name><name><surname>Nourshargh</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Getting to the site of inflammation: the leukocyte adhesion cascade updated</article-title><source>Nature Reviews Immunology</source><volume>7</volume><fpage>678</fpage><lpage>689</lpage><pub-id pub-id-type="doi">10.1038/nri2156</pub-id><pub-id pub-id-type="pmid">17717539</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>C</given-names></name><name><surname>Saito</surname> <given-names>F</given-names></name><name><surname>Liu</surname> <given-names>Z</given-names></name><name><surname>Lei</surname> <given-names>Y</given-names></name><name><surname>Uehara</surname> <given-names>S</given-names></name><name><surname>Love</surname> <given-names>P</given-names></name><name><surname>Lipp</surname> <given-names>M</given-names></name><name><surname>Kondo</surname> <given-names>S</given-names></name><name><surname>Manley</surname> <given-names>N</given-names></name><name><surname>Takahama</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Coordination between CCR7- and CCR9-mediated chemokine signals in prevascular fetal thymus colonization</article-title><source>Blood</source><volume>108</volume><fpage>2531</fpage><lpage>2539</lpage><pub-id pub-id-type="doi">10.1182/blood-2006-05-024190</pub-id><pub-id pub-id-type="pmid">16809609</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>C</given-names></name><name><surname>Ueno</surname> <given-names>T</given-names></name><name><surname>Kuse</surname> <given-names>S</given-names></name><name><surname>Saito</surname> <given-names>F</given-names></name><name><surname>Nitta</surname> <given-names>T</given-names></name><name><surname>Piali</surname> <given-names>L</given-names></name><name><surname>Nakano</surname> <given-names>H</given-names></name><name><surname>Kakiuchi</surname> <given-names>T</given-names></name><name><surname>Lipp</surname> <given-names>M</given-names></name><name><surname>Hollander</surname> <given-names>GA</given-names></name><name><surname>Takahama</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The role of CCL21 in recruitment of T-precursor cells to fetal thymi</article-title><source>Blood</source><volume>105</volume><fpage>31</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1182/blood-2004-04-1369</pub-id><pub-id pub-id-type="pmid">15358618</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname> <given-names>YQ</given-names></name><name><surname>Qin</surname> <given-names>J</given-names></name><name><surname>Wu</surname> <given-names>C</given-names></name><name><surname>Plow</surname> <given-names>EF</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Kindlin-2 (Mig-2): a co-activator of beta3 integrins</article-title><source>The Journal of Cell Biology</source><volume>181</volume><fpage>439</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1083/jcb.200710196</pub-id><pub-id pub-id-type="pmid">18458155</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malinin</surname> <given-names>NL</given-names></name><name><surname>Zhang</surname> <given-names>L</given-names></name><name><surname>Choi</surname> <given-names>J</given-names></name><name><surname>Ciocea</surname> <given-names>A</given-names></name><name><surname>Razorenova</surname> <given-names>O</given-names></name><name><surname>Ma</surname> <given-names>YQ</given-names></name><name><surname>Podrez</surname> <given-names>EA</given-names></name><name><surname>Tosi</surname> <given-names>M</given-names></name><name><surname>Lennon</surname> <given-names>DP</given-names></name><name><surname>Caplan</surname> <given-names>AI</given-names></name><name><surname>Shurin</surname> <given-names>SB</given-names></name><name><surname>Plow</surname> <given-names>EF</given-names></name><name><surname>Byzova</surname> <given-names>TV</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>A point mutation in KINDLIN3 ablates activation of three integrin subfamilies in humans</article-title><source>Nature Medicine</source><volume>15</volume><fpage>313</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.1038/nm.1917</pub-id><pub-id pub-id-type="pmid">19234460</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manevich-Mendelson</surname> <given-names>E</given-names></name><name><surname>Feigelson</surname> <given-names>SW</given-names></name><name><surname>Pasvolsky</surname> <given-names>R</given-names></name><name><surname>Aker</surname> <given-names>M</given-names></name><name><surname>Grabovsky</surname> <given-names>V</given-names></name><name><surname>Shulman</surname> <given-names>Z</given-names></name><name><surname>Kilic</surname> <given-names>SS</given-names></name><name><surname>Rosenthal-Allieri</surname> <given-names>MA</given-names></name><name><surname>Ben-Dor</surname> <given-names>S</given-names></name><name><surname>Mory</surname> <given-names>A</given-names></name><name><surname>Bernard</surname> <given-names>A</given-names></name><name><surname>Moser</surname> <given-names>M</given-names></name><name><surname>Etzioni</surname> <given-names>A</given-names></name><name><surname>Alon</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Loss of Kindlin-3 in LAD-III eliminates LFA-1 but not VLA-4 adhesiveness developed under shear flow conditions</article-title><source>Blood</source><volume>114</volume><fpage>2344</fpage><lpage>2353</lpage><pub-id pub-id-type="doi">10.1182/blood-2009-04-218636</pub-id><pub-id pub-id-type="pmid">19617577</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Margraf</surname> <given-names>A</given-names></name><name><surname>Nussbaum</surname> <given-names>C</given-names></name><name><surname>Rohwedder</surname> <given-names>I</given-names></name><name><surname>Klapproth</surname> <given-names>S</given-names></name><name><surname>Kurz</surname> <given-names>ARM</given-names></name><name><surname>Florian</surname> <given-names>A</given-names></name><name><surname>Wiebking</surname> <given-names>V</given-names></name><name><surname>Pircher</surname> <given-names>J</given-names></name><name><surname>Pruenster</surname> <given-names>M</given-names></name><name><surname>Immler</surname> <given-names>R</given-names></name><name><surname>Dietzel</surname> <given-names>S</given-names></name><name><surname>Kremer</surname> <given-names>L</given-names></name><name><surname>Kiefer</surname> <given-names>F</given-names></name><name><surname>Moser</surname> <given-names>M</given-names></name><name><surname>Flemmer</surname> <given-names>AW</given-names></name><name><surname>Quackenbush</surname> <given-names>E</given-names></name><name><surname>von Andrian</surname> <given-names>UH</given-names></name><name><surname>Sperandio</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Maturation of platelet function during murine fetal development in vivo</article-title><source>Arteriosclerosis, Thrombosis, and Vascular Biology</source><volume>37</volume><fpage>1076</fpage><lpage>1086</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.116.308464</pub-id><pub-id pub-id-type="pmid">28428216</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montanez</surname> <given-names>E</given-names></name><name><surname>Ussar</surname> <given-names>S</given-names></name><name><surname>Schifferer</surname> <given-names>M</given-names></name><name><surname>Bösl</surname> <given-names>M</given-names></name><name><surname>Zent</surname> <given-names>R</given-names></name><name><surname>Moser</surname> <given-names>M</given-names></name><name><surname>Fässler</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Kindlin-2 controls bidirectional signaling of integrins</article-title><source>Genes &amp; Development</source><volume>22</volume><fpage>1325</fpage><lpage>1330</lpage><pub-id pub-id-type="doi">10.1101/gad.469408</pub-id><pub-id pub-id-type="pmid">18483218</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moretti</surname> <given-names>FA</given-names></name><name><surname>Moser</surname> <given-names>M</given-names></name><name><surname>Lyck</surname> <given-names>R</given-names></name><name><surname>Abadier</surname> <given-names>M</given-names></name><name><surname>Ruppert</surname> <given-names>R</given-names></name><name><surname>Engelhardt</surname> <given-names>B</given-names></name><name><surname>Fässler</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Kindlin-3 regulates integrin activation and adhesion reinforcement of effector T cells</article-title><source>PNAS</source><volume>110</volume><fpage>17005</fpage><lpage>17010</lpage><pub-id pub-id-type="doi">10.1073/pnas.1316032110</pub-id><pub-id pub-id-type="pmid">24089451</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mory</surname> <given-names>A</given-names></name><name><surname>Feigelson</surname> <given-names>SW</given-names></name><name><surname>Yarali</surname> <given-names>N</given-names></name><name><surname>Kilic</surname> <given-names>SS</given-names></name><name><surname>Bayhan</surname> <given-names>GI</given-names></name><name><surname>Gershoni-Baruch</surname> <given-names>R</given-names></name><name><surname>Etzioni</surname> <given-names>A</given-names></name><name><surname>Alon</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Kindlin-3: a new gene involved in the pathogenesis of LAD-III</article-title><source>Blood</source><volume>112</volume><elocation-id>2591</elocation-id><pub-id pub-id-type="doi">10.1182/blood-2008-06-163162</pub-id><pub-id pub-id-type="pmid">18779414</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moser</surname> <given-names>M</given-names></name><name><surname>Bauer</surname> <given-names>M</given-names></name><name><surname>Schmid</surname> <given-names>S</given-names></name><name><surname>Ruppert</surname> <given-names>R</given-names></name><name><surname>Schmidt</surname> <given-names>S</given-names></name><name><surname>Sixt</surname> <given-names>M</given-names></name><name><surname>Wang</surname> <given-names>HV</given-names></name><name><surname>Sperandio</surname> <given-names>M</given-names></name><name><surname>Fässler</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2009">2009a</year><article-title>Kindlin-3 is required for beta2 integrin-mediated leukocyte adhesion to endothelial cells</article-title><source>Nature Medicine</source><volume>15</volume><fpage>300</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1038/nm.1921</pub-id><pub-id pub-id-type="pmid">19234461</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moser</surname> <given-names>M</given-names></name><name><surname>Legate</surname> <given-names>KR</given-names></name><name><surname>Zent</surname> <given-names>R</given-names></name><name><surname>Fässler</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2009">2009b</year><article-title>The tail of integrins, talin, and kindlins</article-title><source>Science</source><volume>324</volume><fpage>895</fpage><lpage>899</lpage><pub-id pub-id-type="doi">10.1126/science.1163865</pub-id><pub-id pub-id-type="pmid">19443776</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moser</surname> <given-names>M</given-names></name><name><surname>Nieswandt</surname> <given-names>B</given-names></name><name><surname>Ussar</surname> <given-names>S</given-names></name><name><surname>Pozgajova</surname> <given-names>M</given-names></name><name><surname>Fässler</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Kindlin-3 is essential for integrin activation and platelet aggregation</article-title><source>Nature Medicine</source><volume>14</volume><fpage>325</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1038/nm1722</pub-id><pub-id pub-id-type="pmid">18278053</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muzumdar</surname> <given-names>MD</given-names></name><name><surname>Tasic</surname> <given-names>B</given-names></name><name><surname>Miyamichi</surname> <given-names>K</given-names></name><name><surname>Li</surname> <given-names>L</given-names></name><name><surname>Luo</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>A global double-fluorescent Cre reporter mouse</article-title><source>Genesis</source><volume>45</volume><fpage>593</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1002/dvg.20335</pub-id><pub-id pub-id-type="pmid">17868096</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potocnik</surname> <given-names>AJ</given-names></name><name><surname>Brakebusch</surname> <given-names>C</given-names></name><name><surname>Fässler</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Fetal and adult hematopoietic stem cells require beta1 integrin function for colonizing fetal liver, spleen, and bone marrow</article-title><source>Immunity</source><volume>12</volume><fpage>653</fpage><lpage>663</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(00)80216-2</pub-id><pub-id pub-id-type="pmid">10894165</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prümmer</surname> <given-names>O</given-names></name><name><surname>Fliedner</surname> <given-names>TM</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>The fetal liver as an alternative stem cell source for hemolymphopoietic reconstitution</article-title><source>The International Journal of Cell Cloning</source><volume>4</volume><fpage>237</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1002/stem.5530040402</pub-id><pub-id pub-id-type="pmid">2875117</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname> <given-names>FM</given-names></name><name><surname>Corbel</surname> <given-names>SY</given-names></name><name><surname>Merzaban</surname> <given-names>JS</given-names></name><name><surname>Carlow</surname> <given-names>DA</given-names></name><name><surname>Gossens</surname> <given-names>K</given-names></name><name><surname>Duenas</surname> <given-names>J</given-names></name><name><surname>So</surname> <given-names>L</given-names></name><name><surname>Yi</surname> <given-names>L</given-names></name><name><surname>Ziltener</surname> <given-names>HJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Recruitment of adult thymic progenitors is regulated by P-selectin and its ligand PSGL-1</article-title><source>Nature Immunology</source><volume>6</volume><fpage>626</fpage><lpage>634</lpage><pub-id pub-id-type="doi">10.1038/ni1203</pub-id><pub-id pub-id-type="pmid">15880112</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruppert</surname> <given-names>R</given-names></name><name><surname>Moser</surname> <given-names>M</given-names></name><name><surname>Sperandio</surname> <given-names>M</given-names></name><name><surname>Rognoni</surname> <given-names>E</given-names></name><name><surname>Orban</surname> <given-names>M</given-names></name><name><surname>Liu</surname> <given-names>WH</given-names></name><name><surname>Schulz</surname> <given-names>AS</given-names></name><name><surname>Oostendorp</surname> <given-names>RA</given-names></name><name><surname>Massberg</surname> <given-names>S</given-names></name><name><surname>Fässler</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Kindlin-3-mediated integrin adhesion is dispensable for quiescent but essential for activated hematopoietic stem cells</article-title><source>The Journal of Experimental Medicine</source><volume>212</volume><fpage>1415</fpage><lpage>1432</lpage><pub-id pub-id-type="doi">10.1084/jem.20150269</pub-id><pub-id pub-id-type="pmid">26282877</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scharffetter-Kochanek</surname> <given-names>K</given-names></name><name><surname>Lu</surname> <given-names>H</given-names></name><name><surname>Norman</surname> <given-names>K</given-names></name><name><surname>van Nood</surname> <given-names>N</given-names></name><name><surname>Munoz</surname> <given-names>F</given-names></name><name><surname>Grabbe</surname> <given-names>S</given-names></name><name><surname>McArthur</surname> <given-names>M</given-names></name><name><surname>Lorenzo</surname> <given-names>I</given-names></name><name><surname>Kaplan</surname> <given-names>S</given-names></name><name><surname>Ley</surname> <given-names>K</given-names></name><name><surname>Smith</surname> <given-names>CW</given-names></name><name><surname>Montgomery</surname> <given-names>CA</given-names></name><name><surname>Rich</surname> <given-names>S</given-names></name><name><surname>Beaudet</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Spontaneous skin ulceration and defective T cell function in CD18 null mice</article-title><source>The Journal of Experimental Medicine</source><volume>188</volume><fpage>119</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1084/jem.188.1.119</pub-id><pub-id pub-id-type="pmid">9653089</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname> <given-names>S</given-names></name><name><surname>Nakchbandi</surname> <given-names>I</given-names></name><name><surname>Ruppert</surname> <given-names>R</given-names></name><name><surname>Kawelke</surname> <given-names>N</given-names></name><name><surname>Hess</surname> <given-names>MW</given-names></name><name><surname>Pfaller</surname> <given-names>K</given-names></name><name><surname>Jurdic</surname> <given-names>P</given-names></name><name><surname>Fässler</surname> <given-names>R</given-names></name><name><surname>Moser</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Kindlin-3-mediated signaling from multiple integrin classes is required for osteoclast-mediated bone resorption</article-title><source>The Journal of Cell Biology</source><volume>192</volume><fpage>883</fpage><lpage>897</lpage><pub-id pub-id-type="doi">10.1083/jcb.201007141</pub-id><pub-id pub-id-type="pmid">21357746</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmits</surname> <given-names>R</given-names></name><name><surname>Kündig</surname> <given-names>TM</given-names></name><name><surname>Baker</surname> <given-names>DM</given-names></name><name><surname>Shumaker</surname> <given-names>G</given-names></name><name><surname>Simard</surname> <given-names>JJ</given-names></name><name><surname>Duncan</surname> <given-names>G</given-names></name><name><surname>Wakeham</surname> <given-names>A</given-names></name><name><surname>Shahinian</surname> <given-names>A</given-names></name><name><surname>van der Heiden</surname> <given-names>A</given-names></name><name><surname>Bachmann</surname> <given-names>MF</given-names></name><name><surname>Ohashi</surname> <given-names>PS</given-names></name><name><surname>Mak</surname> <given-names>TW</given-names></name><name><surname>Hickstein</surname> <given-names>DD</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>LFA-1-deficient mice show normal CTL responses to virus but fail to reject immunogenic tumor</article-title><source>Journal of Experimental Medicine</source><volume>183</volume><fpage>1415</fpage><lpage>1426</lpage><pub-id pub-id-type="doi">10.1084/jem.183.4.1415</pub-id><pub-id pub-id-type="pmid">8666900</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scimone</surname> <given-names>ML</given-names></name><name><surname>Aifantis</surname> <given-names>I</given-names></name><name><surname>Apostolou</surname> <given-names>I</given-names></name><name><surname>von Boehmer</surname> <given-names>H</given-names></name><name><surname>von Andrian</surname> <given-names>UH</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A multistep adhesion cascade for lymphoid progenitor cell homing to the thymus</article-title><source>PNAS</source><volume>103</volume><fpage>7006</fpage><lpage>7011</lpage><pub-id pub-id-type="doi">10.1073/pnas.0602024103</pub-id><pub-id pub-id-type="pmid">16641096</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shinkai</surname> <given-names>Y</given-names></name><name><surname>Rathbun</surname> <given-names>G</given-names></name><name><surname>Lam</surname> <given-names>KP</given-names></name><name><surname>Oltz</surname> <given-names>EM</given-names></name><name><surname>Stewart</surname> <given-names>V</given-names></name><name><surname>Mendelsohn</surname> <given-names>M</given-names></name><name><surname>Charron</surname> <given-names>J</given-names></name><name><surname>Datta</surname> <given-names>M</given-names></name><name><surname>Young</surname> <given-names>F</given-names></name><name><surname>Stall</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement</article-title><source>Cell</source><volume>68</volume><fpage>855</fpage><lpage>867</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(92)90029-C</pub-id><pub-id pub-id-type="pmid">1547487</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sligh</surname> <given-names>JE</given-names></name><name><surname>Ballantyne</surname> <given-names>CM</given-names></name><name><surname>Rich</surname> <given-names>SS</given-names></name><name><surname>Hawkins</surname> <given-names>HK</given-names></name><name><surname>Smith</surname> <given-names>CW</given-names></name><name><surname>Bradley</surname> <given-names>A</given-names></name><name><surname>Beaudet</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1</article-title><source>PNAS</source><volume>90</volume><fpage>8529</fpage><lpage>8533</lpage><pub-id pub-id-type="doi">10.1073/pnas.90.18.8529</pub-id><pub-id pub-id-type="pmid">8104338</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sperandio</surname> <given-names>M</given-names></name><name><surname>Pickard</surname> <given-names>J</given-names></name><name><surname>Unnikrishnan</surname> <given-names>S</given-names></name><name><surname>Acton</surname> <given-names>ST</given-names></name><name><surname>Ley</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Analysis of leukocyte rolling in vivo and in vitro</article-title><source>Methods in enzymology</source><volume>416</volume><fpage>346</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1016/S0076-6879(06)16023-1</pub-id><pub-id pub-id-type="pmid">17113878</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Svensson</surname> <given-names>L</given-names></name><name><surname>Howarth</surname> <given-names>K</given-names></name><name><surname>McDowall</surname> <given-names>A</given-names></name><name><surname>Patzak</surname> <given-names>I</given-names></name><name><surname>Evans</surname> <given-names>R</given-names></name><name><surname>Ussar</surname> <given-names>S</given-names></name><name><surname>Moser</surname> <given-names>M</given-names></name><name><surname>Metin</surname> <given-names>A</given-names></name><name><surname>Fried</surname> <given-names>M</given-names></name><name><surname>Tomlinson</surname> <given-names>I</given-names></name><name><surname>Hogg</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation</article-title><source>Nature Medicine</source><volume>15</volume><fpage>306</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1038/nm.1931</pub-id><pub-id pub-id-type="pmid">19234463</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tulunay</surname> <given-names>O</given-names></name><name><surname>Good</surname> <given-names>RA</given-names></name><name><surname>Yunis</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="1975">1975</year><article-title>Protection of lethally irradiated mice with allogeneic fetal liver cells: influence of irradiation dose on immunologic reconstitution</article-title><source>PNAS</source><volume>72</volume><fpage>4100</fpage><lpage>4104</lpage><pub-id pub-id-type="doi">10.1073/pnas.72.10.4100</pub-id><pub-id pub-id-type="pmid">673</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ueno</surname> <given-names>T</given-names></name><name><surname>Liu</surname> <given-names>C</given-names></name><name><surname>Nitta</surname> <given-names>T</given-names></name><name><surname>Takahama</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Development of T-lymphocytes in mouse fetal Thymus organ culture</article-title><source>Methods in Molecular Biology</source><volume>290</volume><fpage>117</fpage><lpage>133</lpage><pub-id pub-id-type="pmid">15361659</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ussar</surname> <given-names>S</given-names></name><name><surname>Moser</surname> <given-names>M</given-names></name><name><surname>Widmaier</surname> <given-names>M</given-names></name><name><surname>Rognoni</surname> <given-names>E</given-names></name><name><surname>Harrer</surname> <given-names>C</given-names></name><name><surname>Genzel-Boroviczeny</surname> <given-names>O</given-names></name><name><surname>Fässler</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Loss of Kindlin-1 causes skin atrophy and lethal neonatal intestinal epithelial dysfunction</article-title><source>PLoS Genetics</source><volume>4</volume><elocation-id>e1000289</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1000289</pub-id><pub-id pub-id-type="pmid">19057668</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ussar</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>HV</given-names></name><name><surname>Linder</surname> <given-names>S</given-names></name><name><surname>Fässler</surname> <given-names>R</given-names></name><name><surname>Moser</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The Kindlins: subcellular localization and expression during murine development</article-title><source>Experimental Cell Research</source><volume>312</volume><fpage>3142</fpage><lpage>3151</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2006.06.030</pub-id><pub-id pub-id-type="pmid">16876785</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname> <given-names>N</given-names></name><name><surname>Löhler</surname> <given-names>J</given-names></name><name><surname>Kunkel</surname> <given-names>EJ</given-names></name><name><surname>Ley</surname> <given-names>K</given-names></name><name><surname>Leung</surname> <given-names>E</given-names></name><name><surname>Krissansen</surname> <given-names>G</given-names></name><name><surname>Rajewsky</surname> <given-names>K</given-names></name><name><surname>Müller</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Critical role for beta7 integrins in formation of the gut-associated lymphoid tissue</article-title><source>Nature</source><volume>382</volume><fpage>366</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.1038/382366a0</pub-id><pub-id pub-id-type="pmid">8684468</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinstein</surname> <given-names>EJ</given-names></name><name><surname>Bourner</surname> <given-names>M</given-names></name><name><surname>Head</surname> <given-names>R</given-names></name><name><surname>Zakeri</surname> <given-names>H</given-names></name><name><surname>Bauer</surname> <given-names>C</given-names></name><name><surname>Mazzarella</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>URP1: a member of a novel family of PH and FERM domain-containing membrane-associated proteins is significantly over-expressed in lung and colon carcinomas</article-title><source>Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease</source><volume>1637</volume><fpage>207</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1016/S0925-4439(03)00035-8</pub-id><pub-id pub-id-type="pmid">12697302</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wernimont</surname> <given-names>SA</given-names></name><name><surname>Wiemer</surname> <given-names>AJ</given-names></name><name><surname>Bennin</surname> <given-names>DA</given-names></name><name><surname>Monkley</surname> <given-names>SJ</given-names></name><name><surname>Ludwig</surname> <given-names>T</given-names></name><name><surname>Critchley</surname> <given-names>DR</given-names></name><name><surname>Huttenlocher</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Contact-dependent T cell activation and T cell stopping require talin1</article-title><source>The Journal of Immunology</source><volume>187</volume><fpage>6256</fpage><lpage>6267</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1102028</pub-id><pub-id pub-id-type="pmid">22075696</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>H</given-names></name><name><surname>Gonzalo</surname> <given-names>JA</given-names></name><name><surname>St Pierre</surname> <given-names>Y</given-names></name><name><surname>Williams</surname> <given-names>IR</given-names></name><name><surname>Kupper</surname> <given-names>TS</given-names></name><name><surname>Cotran</surname> <given-names>RS</given-names></name><name><surname>Springer</surname> <given-names>TA</given-names></name><name><surname>Gutierrez-Ramos</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice</article-title><source>Journal of Experimental Medicine</source><volume>180</volume><fpage>95</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1084/jem.180.1.95</pub-id><pub-id pub-id-type="pmid">7911822</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname> <given-names>F</given-names></name><name><surname>Petrich</surname> <given-names>BG</given-names></name><name><surname>Anekal</surname> <given-names>P</given-names></name><name><surname>Lefort</surname> <given-names>CT</given-names></name><name><surname>Kasirer-Friede</surname> <given-names>A</given-names></name><name><surname>Shattil</surname> <given-names>SJ</given-names></name><name><surname>Ruppert</surname> <given-names>R</given-names></name><name><surname>Moser</surname> <given-names>M</given-names></name><name><surname>Fässler</surname> <given-names>R</given-names></name><name><surname>Ginsberg</surname> <given-names>MH</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The mechanism of kindlin-mediated activation of integrin αIIbβ3</article-title><source>Current Biology</source><volume>23</volume><fpage>2288</fpage><lpage>2295</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2013.09.050</pub-id><pub-id pub-id-type="pmid">24210614</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.35816.021</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Gerhardt</surname><given-names>Holger</given-names></name><role>Reviewing Editor</role><aff><institution>Max Delbrück Centre for Molecular Medicine</institution><country>Germany</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Gerhardt</surname><given-names>Holger</given-names> </name><role>Reviewer</role><aff><institution>Max Delbrück Centre for Molecular Medicine</institution><country>Germany</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Hidalgo</surname><given-names>Andrés</given-names> </name><role>Reviewer</role><aff><institution>Fundación Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain</institution><country>Spain</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;Differential requirement of kindlin-3 for T cell progenitor homing to the non-vascularized and vascularized thymus&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, including Holger Gerhardt as the Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Randy Schekman as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Andrés Hidalgo (Reviewer #2).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>Moretti and colleagues reinvestigate the kindlin-3 knockout mice to study the importance of integrin mediated adhesion during T-cell homing to the thymus. They find that early embryonic homing of fetal liver derived progenitor cells proceeds in the absence of strong integrin adhesion, but post-natal thymus atrophy ensues due to defective homing of bone marrow derived circulating progenitor cells to the vascularised thymus. The authors perform a logical series of experiments to understand the mechanistic basis for the differences in kindlin-3 requirement, and come to the conclusion that increased shear forces present at the later developmental stages interfere with homing of weakly adhesive T-cells.</p><p>Overall this is a carefully executed and well documented study that provides valuable insights into in vivo mechanisms at the interface of mechanobiology and organogenesis. The main finding of a selective defect in kindlin-3 deficient T-cells and their homing mechanism when cardiovascular development has proceeded to drive larger hemodynamic shear forces is considered well worth reporting to a wider scientific audience.</p><p>Having said that, the reviewers agree this main conclusion should be strengthened in two key areas:</p><p>Essential revisions:</p><p>The referees request that you:</p><p>1) Provide a more direct proof of shear rates in thymus or more generally present proof that adhesion of WT vs. kindlin-3 mutants is differentially affected at varying flow/shear values. Is it possible to rescue the defect by lowering shear rates in the thymus, or potentially study T-cell behaviour in organs with different shear rates? Alternatively, you may wish to expand the intravital imaging approach to characterise T-cell adhesion differences under different hemodynamic shear in vivo.</p><p>2) Show that the thymic defects are hematopoietic-derived (i.e. not cause by expression in other cell types). Here they suggest either conditional deletion of kindlin-3, or more practically transferring null T-cells to Wt animals.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.35816.022</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>The referees request that you:</p><p>1) Provide a more direct proof of shear rates in thymus or more generally present proof that adhesion of WT vs. kindlin-3 mutants is differentially affected at varying flow/shear values. Is it possible to rescue the defect by lowering shear rates in the thymus, or potentially study T-cell behaviour in organs with different shear rates? Alternatively, you may wish to expand the intravital imaging approach to characterise T-cell adhesion differences under different hemodynamic shear in vivo.</p></disp-quote><p>We agree with the reviewers that this is a central point of our study. However, in our opinion a direct measurement of shear rates within the developing thymus or alternatively lowering the shear rates within the thymus is technically not feasible also because the mutant mice die shortly after birth.</p><p>We tried to address this point by several other means. Firstly, we transferred a 1:1 mixture of differently labelled CD4 T cells from spleens of kindlin-3-floxed/CD4-Cre positive and negative (control) mice (in total 6x10<sup>6</sup> cells) via a catheter of the carotid artery into wild-type mice. 6 and 2 h before preparation of the cremaster muscle mice were treated by intrascrotal injection of IFNγ and TNFα, respectively, to induce local inflammation and T cell adhesion. We chose the cremaster muscle, because here we easily find vessels with different flow rates. However, we hardly recorded fluorescent cells passing through cremaster muscle venules and only detected very few adherent cells. Thus, unfortunately we were unable to correlate flow rates with the adhesion characteristics of wild-type vs. kindlin-3<sup>-/-</sup> T cells.</p><p>Secondly, since kindlin-3 regulates many, if not all integrin classes expressed on hematopoietic cells ranging from HSCs, platelets, myeloid to lymphoid cells in a similar fashion, we analysed adhesion of wild-type and kindlin-3 mutant PMNs to cremaster muscle venules. These datasets also included the blood flow velocities of the individual vessels and therefore allowed a correlation of the adhesion efficiencies versus shear rates. As shown in <xref ref-type="fig" rid="respfig1">Author response image 1</xref> we found despite a high variance a slight increase in adhesion efficiency at higher shear rates for wild-type PMNs, while adhesion efficiencies rather decreased in kindlin-3<sup>-/-</sup> PMNs at higher shear rates. Since adhesion of kindlin-3<sup>-/-</sup> PMNs is already very low at low shear conditions, we also included measurements on kindlin-3 hypomorphic mice into our analysis, which express 5% of kindlin-3 (Klapproth et al., 2015). These cells show a higher basic adhesion but like kindlin-3<sup>-/-</sup>PMNs decreased adhesion at higher shear rates (see <xref ref-type="fig" rid="respfig1">Author response image 1</xref>).</p><fig id="respfig1"><object-id pub-id-type="doi">10.7554/eLife.35816.020</object-id><label>Author response image 1.</label><caption><title>Adhesion efficiencies of PMNs in cremaster muscle venules of wild-type (WT), Kindlin-3 hypomorph (neo) mice and kindlin-3 knockout (KO) chimeras at indicated shear rates.</title></caption><graphic mime-subtype="jpeg" mimetype="image" xlink:href="elife-35816-resp-fig1-v2"/></fig><p>In a third experimental approach we imaged T cell adhesion to the lymph node vasculature by intravital microscopy. Since kindlin-3 deficient cells hardly adhere to the vascular wall, we adoptively transferred CD4 T cells from wild-type and kindlin-3 hypomorphic mice. Both T cell populations were labelled differently with fluorescent dyes and injected in a 1:1 ratio into wild-type mice (15x 10<sup>6</sup> cells/mouse). Consequently, the distribution of adherent wild-type and kindlin-3 hypomorphic T cells in lymph node vessels with different flow rates was recorded. These experiments showed that wild-type T cells primarily adhered to blood vessels with higher shear rates, whereas kindlin-3 hypomorphic T cells were found in areas with lower blood flow velocities and shear rates. These data are now included in the manuscript in Figure 8G-K.</p><disp-quote content-type="editor-comment"><p>2) Show that the thymic defects are hematopoietic-derived (i.e. not cause by expression in other cell types). Here they suggest either conditional deletion of kindlin-3, or more practically transferring null T-cells to Wt animals.</p></disp-quote><p>To address this question we have performed three sets of experiments. First, we have generated mixed fetal liver cell chimeras, in which we transferred wild-type or kindlin-3<sup>-/-</sup> FL cells (CD45.2) together with wild-type FL cells from congenic B6.SJL mice (CD45.1). Since we have previously shown that kindlin-3 deficient HSCs have a 5-fold reduced homing capacity to the bone marrow (Ruppert et al., 2015), we circumvent the homing defect be transferring 9x more CD45.2 FL cells than FL cells from B6.SJL mice (9:1 chimeras). Chimeras, which received wild-type CD45.2 cells showed a perfect 9:1 ratio in all thymic populations (DN, DP, CD4 and CD8). In contrast, 9:1 kindlin-3<sup>-/-</sup> chimeras showed a strong reduction in the DN population, clearly demonstrating that kindlin-3<sup>-/-</sup>T cell progenitors have a strong disadvantage compared to wild-type cells in homing to the thymus. These data are depicted in Figure 4—figure supplement 1B.</p><p>Second, we conditionally deleted kindlin-3 in the hematopoietic system of kindlin-3-floxed/Mx1-Cre mice. Three weeks after polyIC injection the DN T cell populations from thymi of Cre-positive and Cre-negative kindlin-3-floxed mice were analysed by flow cytometry. These experiments revealed a complete absence of DN cells in conditional kindlin-3<sup>-/-</sup>mice indicating that the T cell progenitor homing defect to the thymus is hematopoietically-derived (see Figure 4—figure supplement 1A).</p><p>Third, in order to directly show that the thymic defects are based on a hematopoietic defect and not caused because kindlin-3 is also expressed in a non-hematopoietic thymic cell type such as epithelial cells, we performed flow cytometric experiments with kindlin-3-EGFP knockin mice, in which we tagged Kindlin-3 C-terminally with EGFP. The mice express normal kindlin-3-EGFP fusion protein levels (unpublished). These experiments show that only CD45 positive cells express EGFP in the thymus. CD31 pos endothelial cells and EpCAM pos thymic epithelial cells are EGFP negative. We show these important data in Figure 4—figure supplement 2.</p></body></sub-article></article>